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SUMMARY 
Phytoalexins, the low molecular weight antimicrobial organic metabolites, are 
produced by plants as the first line of defense against fimgal infection. Small 
polysaccharides and proteins, produced by the invading pathogens, act as elicitors 
triggering the synthesis of phytoalexins in the tissues surroimding the infection 
site. In g;rape\Tnes, resveratrol (3,4',5- trihydroxystilbene) is produced in response 
to fimgal infection by Botrytis cinerea and UV irradiation. Resveratrol is a 
phytoalexin and a polyphenolic con^wund present in human dietary material such 
as peanuts, mulberries, grapes and red wine. It is widely considered to possess 
cardiovascular protective propaties and has also been shown to be 
chemopreventive against various stages of chemically induced carcinogenesis. The 
recent spurt in studies on resveratrol is due to its association with the phenomenon 
of Trench paradox' yMch. refers to the paradoxical finding that the incidence of 
coronary heart disease in the population of Southern France is relatively low 
inspite of high intake of saturated fiits in the diet. 
Studies in this laboratory have established that several classes of plant-derived 
polyphenolic conqx)unds such as flavonoids (Ahmad et ai, 1992; Fazal et al, 
1990), tannins (Bhat and Hadi, 1994; Khan and Hadi, 1998), curcumin (Ahsan and 
Hadi, 1998) and capsaicins (Singh et al., 2001) are themselves capable of causing 
oxidative DNA damage in the presence of transitional metal ions. Also, there is 
considerable evidence in the literature \ ^ c h suggests that the antioxidant activities 
of these conqjounds may not fiilly account for their observed chemopreventive 
effects. It thus appears that prooxidant rather than the antioxidant properties of 
polyphenolic con^unds may be responsible for their observed anticancer and 
^wptosis-inducing ability. Further, we have recently proposed a hypothesis for the 
anticancer and apoptosis-inducing properties of plant-derived polyphenolic 
con^imds that involves mobilization of endogenoiis copper and the consequent 
prooxidant action of these conqwunds (Hadi et al., 2000). The antioxidant action 
of resveratrol is well established but Fukuhara and Miyata (1998) have reported its 
ability to cleave DNA, In view of this, I have examined the prooxidant role of 
resveratrol and have shown that, in agreement with many polyphenolics, it is also 
capable of causing strand scission in DNA in the presence of Cu(II). These studies 
con^rise the first chapter of this thesis. Copper ions are known to be a normal 
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component of chromatin. The results indicate binding of resveratrol to copper ions. 
Resveratrol catalyzes the reduction of Cu(II) to Cu(I) vAach is acconq)anied by the 
formation of 'oxidized product(s)' of resveratrol which in turn also appear to 
catalyze the reduction of Cu(II). Inhibition of DNA cleav^e by Cu(I) specific 
sequestering agent, bathocuproine, confirms Cu(I) to be an essential intermediate 
in the reaction. Inhibition of DNA breakage by catalase, sodium azide and 
superoxide dismutase indicated the role of reactive oxygen species in this reaction. 
Resveratrol was able to generate hydrogen peroxide, siq)eroxide anion and singlet 
ojqrgen radical Strand scission l^ the resveratrol-Cu(II) system was found to be 
biological^ active as assayed by bacteriophage inactivation. 
In the second chapter of this thesis, I have studied the fi-agmentation of BSA by 
resveratrol in the presence of Cu(II). Studies involving bathocuproine and 
scavengers of oxygen fi%e radicals suggest that the firs^^ientation of BSA by 
resveratrol-Cu(II) involves a pathway similar to that responsible for the DNA 
cleavage activity. I have also studied the interaction of resveratrol with proteins. 
Fluorescence absorption studies diow binding of resveratrol to BSA and to other 
proteins. A comparison of the pattern of binding of resveratrol to proteins with 
different L-tryptophan content indicates that resveratrol, in addition to tryptophan, 
may bind to other amino acids and also, non-specificalfy to the proteins. 
The third and last chapter of this thesis is aimed at elucidating the mut^enicity of 
resveratrol in plasmid DNA. Mutations, caused in plasmid Bluescript SK(+) on 
treatment with resveratrol-Cu(II), were characterized by sequencing. A comparison 
of the sequences of mutants with known plasmid sequence revealed that a majority 
of mutations in the treated plasmids were deletions while in the spontaneous 
mutants substitution mutations were more common. There was, however, no 
change in the size of the mutants as evidenced by agarose gel electrophoresis. The 
mutants generated by treatment with resveratrol alone showed preference for 
deletion of guanine base. This is possibly due to the feet that most of the copper in 
the chromatin is associated with guanine bases (Kagawa et ai, 1991; Wacker and 
Vallee, 1959) and such copper is mobilized by resveratrol resulting in mutation at 
that site. The other e^qjeriments described in this chapter indicate binding of 
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resveratrol to DNA and formation of a complex involving resveratrol, copper ions 
and DNA. It is worth mentioning that previous studies in this laboratory have 
shown the formation of a ternary conq)lex of polyphenol, DNA and copper ions, 
which generates oxygen radicals in situ via Cu(I) (Rahman et al., 1989, 1990). 
Therefore, it appears that a similar mechanism operates in the case of resveratrol-
Cu(II) mediated DNA breakage. 
Resveratrol is absorbed after oral ingestion, quickly enters the bloodstream and is 
detectable in different organs, particularly the liver (Bertelli et al., 1996). Further, 
polyphenols are absorbed from the upper gastrointestinal tract and are distributed 
in the body, showing an increased affinity for the heart, liver and kidney (Serafini 
et al., 1998). There is evidence in literature to suggest that resveratrol is capable of 
entering the cells (Ciolino and Yeh, 1999). Also, copper ion has been found at 
higher concentrations in tumor cells as conpared with the normal tissue (Linder, 
1991). These &cts, taken together, suggest that the various anticancer effects and 
apoptotic DNA fragmentation activities of resveratrol and other plant derived-
polyphenolic compounds may be e7q}lained by their ability to mobilize endogerK)us 
or othen^ose increased copper levels in cancer cells. Further, the feet that these 
polyphenolic compoimds are ingested by human populations as part of the iK)rmal 
diet in relatively high concentrations without any adverse reactions points to their 
great potential as putative chemopreventive or therapeutic agents. 
introiutm 
INTRODUCTION 
Oxygen free radicals and Antioxidants 
In the late 1950's free radicals and antioxidants were almost unheard of in the 
clinical and biological sciences but chemists had known about them for years in the 
context of radiation, polymer and combustion technology. In a pioneeriiig paper, 
Gerschman and co-workers (Gerschman et al, 1956) related the toxic effects of 
elevated oxygen levels on aerobes to those of ionizing radiation and proposed that 
oxygen toxicity is due to free radical formation. This concept did not capture the 
imE i^nation of most life scientists, however, imtil the discovery of the superoxide 
dismutase en;^ rmes by McCord and Fridovich (1969). These authors had 
previously observed the ability of several proteins to inhibit the reduction of 
cytochrome c fay xanthine oxidase and they realized that these inhibitory effects 
were due to a novel protein contaminating the other proteins tested. They purified 
this contaminant and thus identified the first enzyme (copper and zinc-containii^ 
superoxide dismutase, CuZnSOD) known to act on a free radical substrate 
(McCord and Fridovich, 1968). Around sanae time, Halliwell (1973) had observed 
that illuminated chloroplasts reduce cytochrome c and this was inhibited by 
catalase. Contamination of commercial catalase by superoxide dismutase (SOD) 
was cited as the phenomenon behind this observatioa The presence of enzymes 
such as SOD and catalase in biological systems suggested the endogenous 
generation of firee radicals and the need to scavenge/remove these. By the 1990's it 
was clear that antioxidant enzymes are not a panacea for aging and disease. What 
has become clearer however is the in^rtance of certain dietary antioxidants in 
preventing life-threatening diseases such as heart disease and certain types of 
cancer (Gutteridge and Halliwell, 2000). 
Free radicals are produced in the body as part of normal metabolism, for example, 
superoxide, O2" and nitric oxide, NO, which have important physiological 
fimctions. In general, free radicals are highly reactive and can attack membrane 
lq)ids generating a carbon radical, which in turn reacts with oxygen to produce a 
peroj^l radical, which may attack adjacent fetty acids to generate new carbon 
radicals. This process leads to a chain reaction producing lipid peroxidation 
products. This ur^lies that a single radical may damage many molecules by 
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initiating lipid peroxidation chain reactions. Because of the potential danaaging 
nature of free radicals, the body has a number of antioxidant defense mechanisms 
that include such enzymes as superoxide dismutase and catalase; copper and iron 
transport, storage proteins; and both water-soluble and lipid-soluble molec\ilar 
antioxidants. Superoxide dismutase removes superoxide anion by accelerating its 
dismutation by about four orders of magnitude; hydrogen peroxide (H2O2) can be 
destroyed by catalase, but the most important hydrogen peroxide removing enzyme 
is glutathione peroxidase, vMch removes hydrogen peroxide by using it to oxidize 
reduced glutathione (GSH) to oxidized glutathione (GSSG) (Halliwell and 
Gutteridge, 1989). 
Free radicals like superoxide anion and hydroxyl radicals (OH) are highly reactive 
and present a challenge to the cellular, morphological and functional integrity of 
the cell Superoxide anion is produced by a one-electron addition to molecular 
oxygen and is generated by activated phagocytes such as neutrophils, monocytes, 
macrophages and eosinophils as part of the mechanism by which they kill foreign 
invaders (Babior and Woodman, 1990). These cells also generate H2O2 from 
oxygen in this process. H2O2 does not contain unpaired electrons and is therefore 
not a free radical. However, it is grouped with free radicals in a collection of 
substances produced by the body that are loosefy termed reactive ojqrgen species 
(ROS). Superoxide anion generation by po^mioiphonuclear leukocytes is elevated 
in imtreated leukemia patients (Devi et al., 2000) indicating the persistence of 
oxidative stress in cancerous condition. Evidence indicates that superoxide anion is 
a divisible substance and can migrate large distances and cross membranes in the 
absence or insufficient response of SOD. Further, the toxicity of superoxide anion 
is mediated either by oxidation of sulfliydryl groups to disulphides in proteins 
thereby activating/inactivating key enzymes or by inducing oxidation-reduction 
flux on reaction of superoxide with free transition metal ions. The generation of 
hydroxyl radical, the most toxic of the potential ROS, is dependent upon the 
presence of transition metals, particularly ferric and cupric ions and it reacts 
immediately with any substance at or close to its site of generation. It is believed 
that an in^Mrtant antioxidant defense is the iron and copper ions binding to 
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proteins whenever possible, so that generation of hydroxyl radicals by the Fenton 
reaction is largely prevented (Gabriele et al., 2000). 
Oxidative stress may result when antioxidant defenses are vmable to cope with the 
production of free radicals and may result from the action of certain toxins or by 
physiological stress (Croft, 1998). Oxidative damage to DNA, proteins and lipids, 
causing DNA strand breaks, proteins degradation and lipid peroxidation, 
respectively, can damage or destroy cells (Gabriele et al., 2000). Even xmder basal 
conditions, aerobic metabolism in biological systems creates ROS that are 
prooxidants. Defense against prooxidant damage of biological molecules, such as 
DNA or lipids, requires both intra- and extra-cellular antioxidant activity. 
Oxidative stress or injury occurs if prooxidants are in excess (Whitehead et al., 
1995). Despite all the physiological Unes of defense, some fi«e radical-related 
dami^e still occurs. End products of lipid peroxidation (lipid hydroperoxides, 
aldehydes such as malonaldehyde, hydrocarbon gases and the F2-isoprostanes) and 
of free radical attack on urate are present in vivo (Evans and Halliwell, 1999; Kaur 
and HaUiwell, 1990). Some 8-hydro:q^deoxyguanosine derived from oxidation of 
guanine residues in DNA is always present in cellular DNA, as are several other 
base oxidation products (Rehman et al., 1998) and proteins damped by free 
radical attack are usually degraded more rapidfy than normal proteins (Dean et al., 
1997). These observations provide evidence for on-going oxidative damage in the 
human body, even in healthy individuals. Free radicals are in[q)licated in the 
aetiology of several neurodegenerative disorders, including Parkinson's disease 
and also participate in processes responsible for the poor survival of embryonic 
brain tissue grafts (Lindvall, 1999). The aging process is also suggested to involve 
the cumulative effects of free radical damage (Harman, 1981). 
ROS are considered to be toxic to cells. However, the molecular detection and 
response of cells to ROS are likely to be among the earliest evolved second-
messenger systems. Moreover, there is evidence that ROS are not only 
pathological but also, in many instances, are used as second messengers by the cell 
in response to growth fectors (Sundaresan et al., 1995). 
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It has been suggested that certain promoters of carcinogenesis act by generation of 
oxygen radicals, this being a common property of these substances. ROS produce 
gross chromosomal alterations in addition to point mutations and thus could be 
involved in the activation or loss of the second wild type allele of a mutated proto-
oncogene or tumor suppressor gene that can occur during tiraior promotion and 
progression, allowing e3q)ression of the mutated phenotype (Wiseman and 
Halliwell, 1996). Fat and hydrogen peroxide are among the most potent promoters 
(Welsch and Aylsworth, 1983). Other well known cancer promoters are lead, 
cadnuum, pborbol esters, asbestos and various quinines. Inflammatory reactions 
lead to the production of o?Q^ gen radicals by phagocytes and this is the basis of 
cancer promotion by asbestos (Hatch et ai, 1980). Many carcinogens which do not 
require the action of promoters and are by themselves able to induce 
carcinogenesis (con:q)lete carcinogens), also produce oxygen radicals. These 
include nitroso con^unds, hydrazines, quinines and potycyclic hydrocarbons. 
Much of the toxk effect of ionizing radiation damage to DNA is also due to the 
formation of ojq^gen radicals (Totter, 1980). The mechanism of action of 
promoters involves the e}q>ression of recessive genes and an increase in the gene 
copy number through chromosome breaks and creation of hemizygosity 
(Varshavsky, 1981). Promoters also cause modification of prostaglandins which 
are intimate^ involved in cell division, differentiation and tumor growth. Most 
data on radical damage to biological macromolecules concerns with the effects of 
radiation on nucleic acids because of the possible genetic effects. However, in 
view of the catalytic role of enzymes, damage to proteins is also considered 
important. It has been suggested that primary o^ Q^ gen radicals, produced in cells 
and their secondary lipid intermediates modify and firagment proteins. The 
products are often more susceptible to enzymatic hydrolysis leading to accelerated 
proteolysis inside and outside cells (Fischer et al, 1982). 
Antioxidant mechanisms 
The protective defense mechanisms against mutagens and carcinogens include the 
shedding of surfece layer of skin, cornea and the alinwntary canal. If oxygen 
radicals play a major role in DNA damage, defense against these agents is 
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obviously of great importance (Totter, 1980). The enzymes that protect cells from 
oxidative damage are superoxide dismutase, catalase, glutathione peroxidase, 
glutathione transferases etc. In addition to these enzymes some small molecules in 
the human diet act as antioxidative agents and presumably have an 
anticarcinogenic effect. Diet can modify the pathophysiological processes of 
various disease processes most of which are known to involve oxidative dam^^e. 
Both the nutrient and non-nutrient conponents of the diet have been recognized for 
their antioxidant and chemopreventive benefits. The possible chemopreventive 
mechanisms include carcinogen blocking activities, antioxidant/antiinflammatory 
activities and antiproliferative/antq)rogressive activities. Carcinogenesis blocking 
activities encompass inhibition of carcinogen uptake, inhibition of carcinogen 
formation or activation, deactivation or detoxification of carcinogens, prevention 
of carcinogen binding to DNA and enhancement of the level of fidelity of DNA 
repair. Antfoxidant/antiinflammatory activity includes scavenging of reactive 
electrophiles and oxygen radicals and inhibition of arachidonic acid metabolism. 
Antiproliferative/antiprogressive activities con:q)rise modvilation of signal 
transduction, modulation of hormonal and growth &ctor activity, inhibition of 
polyamine metabolism, induction of terminal differentiation, restoration of 
immune responses, enhancement of inter cellular communication, restoration of 
timior suppressor fiinction, induction of e^ptosis, telomerase inhibition, correction 
of DNA methylation imbalances, inhibition of angiogenesis, inhibition of basement 
membrane and activation of antimetastasis genes (KellofTef al., 1996). 
Different experimental and epidemiological studies have shown that micronutrients 
present in food can act as antimitotic agents, implicated in cancer initiation, cancer 
progression, or mortality (Ames et al., 1995). Among these fectors, pofyphenols, a 
constituent of different classes of foods and beverages, have been intensely studied 
in recent years. Polyphenols belong to a heterogeneous class of conpounds foimd 
in plant sources; they are potent antiperoxidant agents, interfering with the 
oxidative/antioxidative potential of the cell or acting as fi^ee radical scavengers 
(Fauconneau et al., 1997) and have also been reported to inhibit or enhance 
carcinogenesis and mutagenesis in ejqjerimental animals (Ames, 1983). Their 
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antioxidant action is mediated through the inhibition of phospholipase A2, 
cyclooxygenase, phosphodiesterase, and several protein kinases, and they are 
involved in cell s^nalii^ (Soleas et ai, 1997). The inhibitory effect of dietary 
phenolic compovmds on carcinogenesis is due to the induction of cytochron i^e P450 
and other nnetabolic enzynies (Boyd et al., 1982). The optimum levels of dietary 
antioxidants have not been determined, howeva:, there might be considerable 
variation among individuals. On the other hand, high doses of such compounds 
may lead to deleterious side effects. The differences in cancer rates of various 
populations are generally consklered to be due to environmental and life style 
&ctors such as smoking and dietary carcinogens. Moreover, these differences may 
also be due, in good part, to insufQcient amounts of carcinogens and other 
protective &ctors in the diet (Maugh, 1982). Though polyphenols are found in 
wide variety of dietary materials and have been investigated in detail in context of 
their wide pharmacological properties, a unique and interesting property attributed 
to the polyphenols found in red wine is 'French Paradox'. 
French paradox 
As long back as 1819, Dr. Samuel Black, an Irish physician, noted that although he 
found a high incidence of coronary obstruction at autopsy in Ireland, there was an 
\mexplained paucity of reports of such obstructions coming from France and 
Mediterranean countries (Evans, 1995). He credited this discrepancy to differences 
in the habits of the French population compared with the Irish. 
In 1991, a popular investigative documentary television program in the USA, 60 
minutes, introduced to the American public as well as to physicians, the 
paradoxical finding that in France, despite the intake of about three times as much 
saturated &t as in the USA, there was about one-third the incidence of coronary 
disease (Constant, 1997). This finding became popularly known as "The French 
Paradox". There were several possible explanatbns for this lower morbidity and 
mortality from ischemic heart disease: the French consumed less milk (presumably 
due to a higher prevalence of lactose intolerance) and ate more garlic, cheese, fiiiits 
and vegetables than their American and British counterparts. However, the higher 
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intake of red wine was assumed to be the most likely cause for the relatively low 
incidence of coronary disease in this population. 
Several epidemiological studies have suggested that red wine has some unique 
cardioprotective properties. In 1979, St. Leger and co-workers (St. Leger et al., 
1979), in an 18-country study, reported that the strong negative association 
between alcohol intake and deaths fix)m ischemic heart disease could be attributed 
v^lfy to the consun:q)tion of wine. Research for any con^nents in red wine that 
could have fitvorable effects on either l^ids or atheromas has been concentrated 
mainfy on pol^henol conqx>unds which include pigments (anthocyanines), 
tannins and flavonokls. The term 'phenolic compound' embraces a wide range of 
plant substances that possess an aromatic ring bearing one or more hydroxyl 
substituents. They frequently occtir attached to sugars (gfycosides) and as such 
tend to be water-sohible (Croft, 1998). The flavonoids are the largest single group 
of phenolic con^imds and consist of two benzene rings combined with an 
oxygen-containing pyrone ring. Over 2000 different plant flavonoids have been 
identified. The reason that red wines have more flavonoids than white wines is that 
the grape skins are left in the juice during fermentation. The skin is usually 
removed vfbsa making white wine. The first of the antioxidant polyphenols in red 
wine that attracted the attention of investigators was resveratrol (Figure 1). Its 
glycoside was reported to be an active ingredient in the oriental folk medicine 
kojo-kon, which is used for a multitude of therapeutic purposes (Frankel et al., 
1993). It has now been established beyond doubt that resveratrol is the principal 
coniponent of red wine, responsible for the "French Paradox". 
)H 
)H 
Figure 1; Structure of trans resveratrol (3 ,4 '^ trihydroxystilbene) 
Chemically, resveratrol (3,4',5- trihydrojg^ilbene) is a substance of polyphenolic 
character from the groiq) of phytoalexins - stilbenes and one that exists in cis and 
trans-isomer forms. In natural sources trans-isomers are more common. It has been 
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reported in at least 72 plant species (distributed in 31 genera and 12 femilies). It is 
the parent molecule of a femily of polymers named viniferins (Fremont, 2000). Of 
the two isomers, c/s-resveratrol is more light sensitive and more difficult to purify 
(Trela and Waterhouse, 1996). Formation of the cis isomer occurs from irradiating 
the tram isomer, trans- Resveratrol was first reported in grj^vines {Vitis vinifera) 
in 1976 by Langcake and Pryce who found that the con^und was synthesized by 
leaf tissues in response to fimgai infection or ejqwsure to ultraviolet light 
(Fremont, 2000). The average concentration of resveratrol in red wines ranges 
from 2 to 40 nM (McMurtrey, 1996). Fresh grape skin contains about 50 to 100 |ig 
of resveratrol per gram and the concentration in red wine is in the range of 1.5 to 3 
mg/liter (Jang et al, 1997). 
Phytoalexins are organic metabolites that are produced by plants in response to 
fungal infection or abiotics such as heavy metal ions or UV light (Adrian et al., 
1996). They are essentially low molecular weight antimicrobial substances that are 
produced by plants in response to infection by frmgi or bacteria and help to defend 
plants by inhibiting the growth of invading microbes. Phytoalexins vary in their 
chemical nature; for example, in legumes they are mainly isoflavonoids, whereas 
in the potato femily (Solanaceae) they are predominantly terpenes. Substances, 
such as small pofysaccharides and proteins that are produced by the invading 
pathogen, act as elicitors, tr^ering the synthesis of phytoalexins in the tissues 
surroimding the infection site. The production of phytoalexins is one conqx)nent of 
a broader defensive reaction, known as hypersensitivity. These conqraunds have 
been shown to be closely related to the resistance of grapevines to gray mold 
caused by Botrytis cinerea. In grapevines, the response to stresses, e.g. fungal 
infection and UV irradiation, includes the production of resveratrol and its 
glucoside together with the biosynthetically related compounds viniferins and 
pterostilbene (trans-3,5 dimethoxy-4'-hydroxystiIbene) (Jeandet et al., 1997). 
Since resveratrol is a phytoalexin produced in response to injury, its concentrations 
vary widely in different plants as well as in the same plant at different times 
(Siemann and Creasy, 1992). In a pioneering work of increased disease resistance 
in transgenic plants based on an additional foreign phytoalexin, Hain et al. (1993) 
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generated tobacco plants containing stUbene synthase genes jfrom grapevine and 
this resulted in increased resistance to infection by Botrytis cinerea. Resveratrol 
has a fiingicidal effect and it has been shown that at a concentration of 160 ng/mL, 
resveratrol con^iletely inhibits the germination of the conidia ofB. cinerea (Paul et 
al, 1999). 
Synthesis of resveratrol 
Resveratrol is synthesized by the enzyme stilbene synthase (STS, E.G. 2.3.1.95) 
wrhich is a plant polyketide synthase betonging to the chalcone synthase 
super&mily. STS is a homodimer of identical subunits of 43kDa and catalyzes 
repetitive decarbo^ktive Claisen condensation of a pheny^ropanoid CoA-ester 
(e.g. /?-coumaroyl-CoA) residue with three Cj-units fix)m malonyl-CoA leading to 
a linear tetraketide intermediate (Yamaguchi et al.y 1999). Further, STS catalyzes 
cyclization of this linear molecule to yield resveratrol The cyclization involves 
carbons 2 and 7 and is accompanied by the removal of the terminal carboxyl group 
(Suh et al., 2000). However, it is to be noted that the STS-type cyclization is a 
complex process. In general, STS-type reaction involves hydrolysis, cyclization 
and decarboxylation, although the order of events is yet to be resolved (Suh et al., 
2000). A putative scheme for the synthesis of resveratrol is given in Figure 2. 
Darakchasava, a well known Indian ayurvedk; medicine, prescribed as a 
cardiotonic and also given for other disorders has Vitis vinifera L. as the main 
ingredient and has been foimd to contain 38.8296 ng of rra/is-resveratrol per 30|xl 
of the herbal preparation (Paul et al., 1999). This corresponds to 1.296 mg/1 
resveratrol However, different sanqiles of Darakchasava from different 
pharmaceutical conq}anies were found to vary in resveratrol content and the 
variation ranged from 1.296 to 6.004 mg/1 resveratrol Occurrence of trans-
resveratrol has also been reported in the roots of Polygonum cuspidatum, an 
inqxjrtant con^x)nent of Chinese herb medicine used to treat lipid disorders (Tsan 
et al., 2000). /ra/ty-Resveratrol is also available as a nutraceutical product (Creasy 
and Creasy, 1998). However, in spite of the enormous data on the beneficial effects 
of resveratrol on human health, its unhealthy effects cannot be conq)letely ruled 
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out. Recently, Kitson et al. (2001) have speculated such effects of resveratrol in 
view of its very close structural similarity with synthetic hormone-mimic 
diethylstilbesterol which has been reported to cause delayed cancer in the 
daughters of mothers who have been administered the drug during pregnancy 
(Hatch era/., 1998). 
S-CoA 
malonyl-CoA 
S-CoA 
p-coumaroyl-CoA 
f^  CoASH + CO2 
o o 
fr^^-^-coA 
malonyl-CoA-^i 
matonyl-CoA--* 
V 
S-CoA 
^ C O , 
OH 
trans Resveratrol 
Fieure 2; Schematic representation of the synthesis oi trans resveratrol 
Antioxidant activity of resveratrol 
Frankel et al. (1993) first reported the antioxidant activity of resveratrol on copper-
induced low density lipoprotein peroxidation and Belguendouz et al. (1997) 
attributed this activity of resveratrol to its ability to chelate copper ions. 
Fauconneau et al. (1997) indicated that resveratrol, together with polyphenols fi-om 
15 
INTRODUCTION 
Vitis vinifera, inhibits Fe^ -^induced microsomal lipid peroxidation. Subsequently, 
the ability of resveratrol to scavenge lipid peroxyl and/or carbon-centred radicals 
has been reported (Miura et al, 2000). Resveratrol has been reported to inhibit 
superoxide radical and hydrogen peroxide produced by noacrophages stimulated by 
lipopofysaccbarides or phorbol esters (Martinez and Moreno, 2000). It has also 
been shown to inhibit generation of superoxide radicals in blood platelets (Olas et 
al, 2001). It protects kidney of KBrOa-challenged rats against oxidative damage 
(Cadenas and Barja, 1999) and rat embryonic mesencephalic tissue, rich in 
dopaminergic neurons, &om the prooxidant tert-h\xty\ hydroperoxide (Karlsson et 
al., 2000). Resveratrol has also been shown to reduce renal ischemia reperfusion 
injiiry th ro i^ a nitric oxide-dependent mechanism (Giovannini et al., 2001). 
Amph^thic property of resveratrol is considered in^rtant by some workers in 
context of its ability to scavenge lipid hydroperoxyl free radicals as well as the 
hydroxyl and superoxide anion radicals (Kahl, 1991; Karlsson et al., 2000). 
Neuroprotective ability of resveratrol arising because of its antioxidant properties 
has also been suggested (Bastianetto et al., 2000; Chanvitayapongs et ah, 1997; 
Huang et al., 2001; Sun and Sun, 2001). The antioxidant properties of resveratrol 
in relation to its antiproliferative properties have also been reported (Moreno, 
2000). Several other studies have reported the direct as well as indirect radical 
scavenging activity of resveratrol supporting its antioxidant action (Burkhardt et 
al, 2001; Fauconneau et al, 1997; Kanpa et al, 2000; Miller and Rice-Evans, 
1995; Murcia and Martinez-Tome, 2001; Soleas et al, 1997; Stojanovic et al, 
2001; Zou et al, 1999). A study \^^ch puts a question mark on the antioxidant 
activity of resveratrol is that of Babich and co-workers (Babich et al, 2000) in 
which a cytotoxicity profile of resveratrol to human gingival epithelial Smulow-
Glickman (S-G) cells has been provided. In this study irreversible damage to cell 
proliferation, possibly due to inhibition of DNA synthesis, was noted in S-G cells 
exposed to 75-150 \iM resveratrol for 2 days. In a study suggestive of the direct 
prooxidant action, resveratrol has been shown to cleave plasmid pBR322 DNA in 
the presence of Cu(II) (Fukuhara and M^ata, 1998). A copper-peroxide complex 
rather than the freely difiusible oxygen species was imphcated as the factor 
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responsible for this DNA damage. In a subsequent study, resveratrol was shown to 
promote hydroxyl-radical formation by DNA-bound Cu(II) ions, a property which 
was, however, lost in the presence of either ascorbic acid or glutathione (Burkitt 
and Ehmcan, 2000). 
Anti-cancer activity of resveratrol 
Strong epidemiological evidence indicates that the consumption of diets rich in 
plant materials is associated with a reduced risk of cancer (Steinmetz and Potter, 
1996). A central tenet of current chemoprevention theory is that minor dietary 
constituents, particularly from plant sources, may exert profound biok>gical effects 
that thereby inhibit carcinogenesis (Gescher et ah, 1998). Cycbox/genases (COX) 
catafyze the synthesis of prostaglandins (PGs) from arachidomc acid. There are 
two isoforms of COX, designated COX-1 and COX-2. COX-1 is expressed 
constitutively in most tissues and {q)pears to be responsible for house keeping 
fiinctions (Funk et ai, 1991). By contrast, COX-2 is not detectable in most normal 
tissues but is induced by oncogenes, growth &ctors, carcinogens, and timior 
promoters (Subbaramaiah et al., 1996.). Multiple lines of evidence support the idea 
that COX-2 is impoTtmA in carcinogenesis. Thus, COX-2 is upregulated in 
transformed cells (Kutchera et al., 1996; Subbaramaiah et al., 1996) and in 
malignant tissues (Parett et al., 1997; Ristimaki et al., 1997). A null mutation for 
COX-2 in APC^''* knockout mice, a murine model of &milial adenomatous 
polyposis, markedly reduces the number and size of intestinal tumors (Oshima et 
ai, 1996). These studies suggest that targeted inhibition of COX-2 is a promising 
approach to prevent cancer. 
Resveratrol has been shown to block tumorigenesis in a two-stage model of skin 
cancer that was promoted by treatment with phorbol ester (PMA) and 12-0-
tetradecanoylphorbol-13-acetate (TPA) (Jang et al., 1997). Subbaramaiah and co-
workers (Subbaramaiah et al., 1998) have shown that resveratrol suppressed PMA-
mediated induction of PG synthesis at least, in part, by inhibiting COX-2 gene 
expression. Tumor-promoting phorbol esters induce COX-2 gene e3q)ression by 
activating the protein kinase C (PKC) pathway. A downstream target of activated 
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PKC is the AP-1 transcription factor complex. Resveratrol has been shown to 
suppress PMA-mediated activation of COX-2 transcription by inhibiting the PKC 
signal transduction pathway at multiple levels (Subbaramaiah et al, 1999). In this 
study it was shown to block both PMA-induced translocation of PKC activity from 
cytosol to membrane and the increase in COX-2 promoter activity mediated by c-
Jun. These studies are significant in view of the feet that PKC activity is 
upregulated in some cancers and is considered a potential target for anticancer 
therapy. Additionally, because AP-1 has been implicated in promoting 
carcinogenesis, these effects are likely to contribute to the antitumor activity of 
resveratrol. Resveratrol is also regarded as a specific COX-1 inhibitor (Brzozowski 
et al, 1999) in addition to being a potent inhibitor of COX-2 (Subbaramaiah et al, 
1998). 
TPA treatment induces oxidative stress, as evidenced by numerous biochemical 
responses, including significant generation of H2O2 and enhanced levels of 
myeloperoxidase and oxidized glutathione reductase activities and decrease in 
glutathione levels and superoxide dismutase activity. TPA treatment also elevates 
the ejqjression of COX-1, COX-2, c-myc, c-fos, c-Jun, transforming growth fector-
(31 (TGF-pi) and tumor necrosis fector-a (TNF-a) (Kennard et al, 1995). 
However, pretreatment of mouse skin with resveratrol was foimd to negate several 
of these TPA-induced effects in a dose-dependent manner (Jang and Pezzuto, 
1998). In this study it was suggested that resveratrol inhibits tumorigenesis through 
interference with pathways of reactive oxidants and possibly by modulating the 
expression of c-fos and TGF-pi. Another property of resveratrol that is relevant to 
its tumor suppression activity is its ability to increase gap-junctional intercellular 
communication (GJIC) (Nielsen et al, 2000) since tumor promotion is 
accompanied by inhibition of GJIC (Yamasaki and Naus, 1996). 
Inhibition of carcinogen activation, either through the direct inhibition of activating 
enzymes or through the inhibition of the signal transduction leading to their 
transcriptional activation, is a characteristic of the so-called "blocking" type of 
chemopreventive agent (Wattenberg, 1997). Resveratrol is a inhibitor of several 
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liver microsomal enzymes and has been shown to exhibit potent inhibition of 
alkoxyresorufin 0-dealkylase activity, a measure of cytochrome P450 activity 
(Teel and Huynh, 1998). Resveratrol also inhibits, in vitro, the catalytic activity of 
human recombinant cytochrome P450(CYP)3A4 (Chan and Dehicchi, 2000) and 
CYP3A5 (Chang and Yeung, 2001). This group of enzymes is clinically in^rtant 
because they are major catafysts in the hepatic biotransformation of many drugs. 
Moreover, CYP3A4 has a significant in j^act on the pre-systemic clearance and 
bioavailability of a drug because of the presence of this enzyme in the 
gastrointestinal tract. Resveratrol has also been demonstrated to inhibit the 
expression of CYPlAl in vitro (Ciolino et a/., 1998) and CYP1A2 in microsomes 
and intact HepG2 human hepatoma cells (Ciolino and Yeh, 1999). Chim and co-
workers (Chun et al., 1999) have described resveratrol to be one of the most 
selective natural inhibitors of human CYPIAI. Aryl hydrocarbons, a class of 
highly potent carcinogens, are activated to genotoxic metabolites by CYPIA 
femily of enzymes, which catafyze the oxidation of the hydrocarbon to a variety of 
diol epoxides, >^ch are potent binders of DNA. Inhibition of CYPIA enzyme 
activity may be an important mechanism in the chemopreventive effect of 
resveratrol that has been associated with a reduced risk of carcinogenesis. 
Resveratrol inhibits the proliferation of human prostrate cancer (Hsieh and Wu, 
1999; Kampa et al., 2000; Mitchell et al., 1999), breast epithelial carcinoma (Hsieh 
et al., 1999*; Lu and Serrero, 1999; Mgbonyebi et al., 1998), monocytic leukemia 
(Gautam et al., 2000), promyelocytic leukemia (Clement et al., 1998; Delia 
Ragione et al., 1998; Gautam et al., 2000), tongue squamous carcinoma (ElAttar 
and Viiji, 1999) and colonic carcinoma (Schneider et al., 2000; Tessitore et al., 
2000; Wolter et al., 2001) cells. Resveratrol also has the potential of inhibiting 
hepatic cancer by virtue of its ability to deactivate human liver myofibroblasts 
which are involved in the development of liver fibrosis and cancer progression 
(Godichaud et al, 2000). A recent study has indeed demonstrated that resveratrol 
decreases hepatocyte growth &ctor-induced human hepatoma cell line HepG2 cell 
invasion (De Ledinghen et al., 2001). However, resveratrol has been found to be 
ineffective, at a dose of 500 ppm, against lung tumor induction in A/J mice by the 
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tobacco smoke carcinogens benzo[a]pyrene and 4-(methyl-nitrosamino)-l-(3-
pyridyl)-l-butanone (Hecht et al, 1999). 
An interesting observation is that human leukemia cells are more sensitive to 
resveratrol than jS s^hly isolated normal human peripheral blood lymphocytes 
(Clement et al., 1998). Similarly, Tsan and colleagues (Tsan et al., 2000) observed 
that resveratrol inhibits the growth of THP-1 cells by inducing apoptosis, while 
having no effect on differentiated THP-1 cells. Tessitore and co-workers (Tessitore 
et al., 2000) observed enhancement by resveratrol of feox ejq)ression in the aberrant 
crypt foci but not in the surroimding mucosa suggesting that resveratrol may 
protect against carcinogenesis by increasing apoptosis in tumor tissues/cells 
selectively. Resveratrol was also found to irreversibly inhibit mouse and human 
leukemic cell lines while its effect on normal hematopoietic progenitor ceUs was 
found to be reversible (Gautam et al., 2000). However, in a recent study it has been 
reported that resveratrol is enable of inhibiting the viability and proliferation of 
cultured normal human keratinocytes (HoUan and Walter, 2001). Considerable 
evidence suggests that many anti-cancer drugs, irrespective of their intracellvilar 
targets and mechanisms of action, exert their biological effect by triggering a 
common apoptotic death pathway in their target cells, which include leukemias, 
lyn^homas and solid tumors (Friesen et al., 1996; Hannun, 1997) 
Resveratrol and Apoptosis induction 
Apoptosis is a form of programmed cell death and is a tightly regulated process 
involving changes in the expression of distinct genes. Inhibition of apoptosis is one 
mechanism of timior formation and many chemopreventive agents may act through 
the induction of apoptosis to block the carcinogenic process (Fisher, 1994). There 
is evidence in literature which indicates that apoptosis may represent a protective 
mechanism against neoplastic development by eliminating genetically damaged 
cells or excess cells that have inq)roperly been induced to divide by fectors such as 
carcinogens (Hickman, 1992). In agreement with the findings that cancer 
chemopreventive agents can iiMluce apoptosis (Fesus et al., 1995; Samaha et al., 
1997), resveratrol has also been shown to induce apoptosis in various cancer cell 
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lines. Clement and co-workers first demonstrated induction of apoptosis by 
resveratrol in both solid and non-solid cancer cells by triggering the CD95 
signaling system (Clement et al., 1998). However, in a recent report (Dorrie et ai, 
2001), it has been reported that apoptosis induction by resveratrol is iiKiependent of 
CD95 signaling and possible involves a nutochondria/caspase-9-specific general 
pathway for the activation of the caspase cascade. In yet another report, resveratrol 
has been shown to induce apoptosis via a bcl-2 controlled novel mitochondrial 
pathway (Tinhofer et al., 2001). i^ptosis induction by resveratrol has been 
reported in human promyelocytic leukemia (HL-60) cells (Surh et ai, 1999) and in 
human myeloid leukemic (U937) cell line (Bertelli et al., 1999). In THP-1 human 
monocytic leukemia cells, resveratrol-induced ^xjptosis has been shown to involve 
a Fas signaling independent pathway (Tsan et al., 2000). Related to the cancer 
chemopreventive properties, resveratrol has been shown to induce apoptosis in 
fibroblasts after the induced ejq)ression of oncogenic U-ras (McNary and Baldwin, 
2000). Using a mouse JB6 epidermal cell line, Huang et al. (1999) observed that 
resveratrol-induced apoptosis occurs only in cells e)q)ressing wild-type p53 
(pSS*'^, but not in p53-deficient (p53''") cells, while there is no difiTerence in 
apoptosis induction between normal lynq)hoblasts and sphingomyelinase-deficient 
cell lines. Further, She and co-workers (She et al., 2001) have elucidated the 
potential signaling conqx)nents underlying resveratrol-induced p53 activation and 
induction of apoptosis. A recent study has, however, reported the resveratrol-
induced apoptosis to be p53 and p21-independent (Roemer and Roemer, 2001). 
The p53 gene is an established tumor suppressor and an inducer of apoptosis and 
Soleas and co-workers have speculated that the putative anticarcinogenic 
properties of resveratrol are unlikely to be mediated by modulation of p53 gene 
ejq)ression (Soleas et al, 2001*). The expression of bcl-2, a protooncogene 
involved in regulating apoptosis has been shown to be decreased on resveratrol 
treatment (Surh et al., 1999). 
Apoptosis also plays an important role in regulating the number of neuronal cells 
during the development of the central nervous system. Apoptosis is involved in 
neuronal loss which occurs in various human neurodegenerative disorders, such as 
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Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis and spinal 
muscular atrophy. In a study involving induction of apoptosis by low K in 
cultured cerebellar granule neurons it was found that 5-200 i^M trans- and cis-
resveratrol had no protective role against apoptotic induction (Ruvo et al., 2000). 
In a more recent report it has been shown that resveratrol inhibits anticancer drug 
paclitaxel-induced cell death in human neuroblastoma cell line SH-SY5Y (Nicolini 
era/., 2001). 
Similar to the conflicting reports on anticancer activity of resveratrol, there are 
mixed reports on the induction of apoptosis by this chemopreventive agent. 
Resveratrol has been shown to prevent apoptosis induced in human 
erythroleukemia K562 cells \sy hydrogen peroxide and other unrelated stimuli 
(Maccarrone et al., 1999). This activity of resveratrol has been attributed to its 
ability to inhibit main arachidonate-metabolizing enzymes namefy, 5-l^xygenase 
and prostaglandin H synthase. In a study involving human colon cancer ceUs, no 
apoptosis was observed on resveratrol treatment (Schneider et al., 2000). However, 
in LNCaP prostate cancer cells it was found that a lOO^M treatment of resveratrol 
caused inhibition of cell growth in the presence of androgens with little detection 
of apoptosis, >^*ereas 200|iM resveratrol induced massive apoptotic ceU death 
(Mitchell et al, 1999). Halliwell (2000) has attributed the contradictory results of 
apoptosis induction by antioxidants to the oxidation state of the cell; apoptosis is 
accompanied by an intracellular shift towards increased oxidation, but too much 
oxidation stops apoptosis by oxidizing and inactivating the caspase enzymes 
(Hanq t^on and Orrenius, 1998). Thus, resveratrol can sometimes suppress 
apoptosis aiKl sometimes fecilitate it. 
Resveratrol has been shown to protect K562 cells against oxidative stress-induced 
apoptosis as well as that induced by 5-hydroxyeicosatetraenoic acid, cisplatin and 
transforming growth fector bl (Maccarrone et al., 1999) while stilbene and stilbene 
oxide were found to be ineffective, suggesting an essential requirement of the 
presence of hydroxyl groups in resveratrol for many of its physiologically relevant 
activities. 
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Estrogenic effect of resveratrol 
Resveratrol is similar in structure to the synthetic estrogen diethylstilbestrol and 
has been shown to exhibit estrogenic activity (Gehm et al, 1997), a property that is 
known to have a protective benefit against cardiovascular disease. However, the 
estrogenic effects of resveratrol should be viewed with caution. It has been 
reported that phytoestrogens inhibit growth in both estrogen receptor-positive and 
estrogen-negative cell lines (Wang et al., 1996). It would thus appear that the 
inhibitory effects of resveratrol are onfy partly mediated by estrogen receptors 
(Mizutani et al., 2000). In feet resveratrol has been shown to possess antiestrogenic 
activity as well (Lu and Serrero, 1999). In an interesting study (Basly et al., 2000) 
on estrogenic/antiestrogenic properties of resveratrol it has been shown that at 
medium concentrations (10 and 2S\\M) resveratrol exerts strong estrogenic effects 
and increases the in vitro growth of MCF-7 cell lines. Low concentrations (0.1 and 
l(iM), however, had no effect -VMR the high concentration (SO i^M) decreased cell 
growth and was cytotoxic. These results are same as observed by Hsieh et al. 
(1988) with genistein (4,5,7-trihydroxyisoflavone), present in soy-based diets, 
where a mitogenic effect of genistein at low doses (O.Ol-ljxM) and an 
antiproliferative effect at higher doses (> 10^M) was reported. Prior to these 
studies, Wang et al. (1996) had shown stimulation and then inhibition by genistein 
in a dose-dependent manner of the growth of MCF-7 cells. These studies and 
others (Bouker and Clarke, 2000) suggest that genistein can act as both an estrogen 
and an antiproliferative agent. A similar scenario seems to exist for resveratrol as 
well. A recent study has suggested that the antiproliferative effect of resveratrol in 
Ishikawa cells is mediated by both estrogen-dependent and -independent 
mechanisms (Bhat and Pezzuto, 2001). The estrogenic and antiproliferative effects 
of resveratrol may be both dose- and tissue-dependent. It is therefore plausible that 
resveratrol has different effects on various tissues in the presence of high estrogen 
levels (such as during pregnancy), moderate levels (such as durii^ premenopausal 
life) and low levels (such as during childhood and postmenopause). A recent study, 
however, questions the estrogenicity of resveratrol and the cardiovascular benefits 
of red wine arising because of it. In this study, Freyberger and co-workers 
(Freyberger et al, 2001) could not substantiate an estrogenic potential of 
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resveratrol in vivo in spite of using the most effective route of administration and 
the plasma levels of resveratrol in the range reported to be effective in vitro. 
Most estrogenic phytochemicals includii^ resveratrol, flavonoids and 
isoflavonoids are capable of generating superoxide anion in the presence of 
molecular oxygen. In the context of estrogenic activity of a number of 
phytochemicals it may be of interest to mention that the effect of ROS on cell 
proliferation could be analogous to that shown by genistein, resveratrol etc. It has 
been reported that several geiK transcription fectors require transient oxidation for 
their function (Sen, 1998), so that low quantities of ROS often stimulate cell 
proliferation (Burdon, 1995) and high concentrations are inhibitory. It is thus 
pertinent to speculate that the estrogenic activity of phytochemicals is mediated by 
their capacity to generate oxygen free radicals in vivo. 
In an interesting study, resveratrol has been found to inhibit herpes simplex virus 
types 1 and 2 (HSV-1 and HSV-2) replication in a dose-dependent, reversible 
manner (Docherty et al., 1999). It is noteworthy that HPS is a DNA virus. 
Resveratrol is also an inhibitor of DNA potymerase (Sun et al, 1998). In the study 
involving HSV, resveratrol was found to delay the cell cycle at S-G2-M interphase 
(Docherty et al, 1999). The impairment of cell cycle progression observed with 
resveratrol may, at least in in vitro models, be due to its ability to inhibit enzyme 
activities essential for DNA synthesis, such as DNA polymerase (Sun et al., 1998) 
and ribonucleotide reductase (Fontecave et al., 1998). Using endothelial cells, 
Hsieh et al. (1999**) have shown suppression of cell proliferation by resveratrol and 
perturbed progression through S and G2 phases of cell cycle. Park et al. (2001) 
observed the cell cycle arrest induced by resveratrol to be concentration-dependent, 
the induction being significant at low concentrations and almost no induction at 
high concentrations. 
The other properties of resveratrol include inhibition of sodium-independent 
glucose transport (Park, 2001) and inhibition of enzymes xanthine oxidase (related 
to the disorders such as gout and renal stones) and monoamine oxidase (related to 
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the treatment of some mental diseases including depression, anxiety and 
Parkinson's disease) (Zhou et al, 2001). Resveratrol has also been associated with 
suppression of angiogenesis (Brakenhielm et al, 2001; Igura et al, 2001), anti-
glomerulonephritic activity (Nihei et al, 2001), antibacterial activity (Daroch et 
al, 2001) and selective inhibition of Neisseria gonorrhoeae and Neisseria 
meningitides (Docherty et al, 2001). Further, since resveratrol inhibits 
ribonucleotide reductase as does hydroxyurea, the first therapeutic agent used in 
the treatment of sickle cell disease, it possesses the potential of being used in sickle 
cell disease ther^y (Rodrigue et al, 2001). 
Absorption of resveratrol 
Resveratrol is absorbed after oral ingestion, quickly enters the bloodstream, is 
detectable in different organs, in particular, the liver (Bertelli et al, 1996) and 
reaches its peak concentration of 25 ng/ml 60 minutes after wine ingestion (100 ng 
resveratrol/kg). It may be mentioned that polyphenols are absorbed firom the upper 
gastrointestinal tract and are distributed in the body, showing an increased afBnity 
for the heart, liver and kidney (Serafini et al, 1998). In plasma, resveratrol is 
mainly present in the conjugated form - glucoronide and sul&te (Soleas et al, 
200l'0- Kuhnle et al (2000) have shown that the major product (-99%) transferred 
across the intestinal epithelium is a glucuronide of the parent resveratrol aglycone, 
with 4'-hydroxyl group being the preferential glucuronidation site. Though 
glucuronides of phenolic con^unds are generally believed to be 
pharmacologically inactive, there are reports that some drug glucuronides may be 
pharmacologically active. For exanq)le, the analgesic action of morphine-6-
glucuronide has been reported (Joel et al, 1985). Moreover, it is conceivable that 
P-glucuronidases, present in a variety of organs and body fluids, can cleave back 
resveratrol glucuronide to the pharmacologically active aglycone form. Phenol 
sulphotransferase (E.C. 2.8.2.1) is capable of sulphating resveratrol in the human 
liver and duodenxmi which limits its bioavailability but such sul&tion is inhibited 
by dietary components such as quercetin, thus inq)roving its bioavailability 
(DeSanthiera/., 2000). 
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It has been observed that wine polyphenols, including resveratrol, at the same 
concentrations as those found in plasma after moderate wine consumption, are 
important cofectors in antiinfective, antiinflammatory and anticancer nonspecific 
immune reactions (Bertelli et ai, 1999). Also, a recent report (Kampa et al., 2000) 
has shown the biological activity of resveratrol at nanomolar concentrations. There 
is evidence in literature to suggest that resveratrol is capable of entering the cells 
(Ciolino and Yeh, 1999). As mentioned above, resveratrol probably has potential 
positive health benefits. Controversy, however, is focused on \^ diether the amounts 
of resveratrol found in wine (ranging fi'om 2 to 40 fiM) are significant to induce a 
pharmacological role in vivo. As noted by Bertelli et al. (1998), if one considers 
the dosages of resveratrol used by many investigators in tests carried out in 
laboratory animals, or in vitro on tissue culture or cellular preparations, it is 
apparent that to obtain similar effects, rather high doss^es of resveratrol should be 
consumed by humans. Pace-Asciak et al. (1996) found a s^nificant inhibition of 
platelet fimctions in humans who consumed 2 mg of resveratrol per day as wine or 
grape juice, suggesting that resveratrol consumption fiY)m wine and other dietary 
sources may produce pharmacologicaUy active concentrations. Pendurthi et al. 
(1999) observed that in addition to fi«e /rans-resveratrol, most red wines contain 
high concentrations of cw-resveratrol and resveratrol glycosides that could also 
contribute to the biologically active dose for total resveratrol consumptioa 
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The pharmacological effects of plant-derived polyphenols, including resveratrol, 
tannins, flavonoids, capsaicin and cvircuniin have been linked to their known 
flinctions as strong antioxidants. Most clinically used anticancer drugs can activate 
late events of apoptosis (DNA degradation and morphological changes) and there 
are differences in essential signaling pathways between pharmacological cell death 
and physiological induction of programmed cell death (Smets, 1994). Therefore, it 
spears that other mechanisms may also be responsible for these effects and 
studies in this laboratory (Ahmad et al., 1992; Ahsan and Hadi, 1998; Bhat and 
Hadi, 1994; Singh et al, 2001) have confirmed that polyphenolic compounds are 
themselves capable of oxidative DNA cleavage particularly in the presence of 
transition metal ions such as copper. DNA breakage by these compounds in the 
presence of copper ions correlates with apoptosis inducing c^jacity. There is 
evidence to suggest that the antioxidant properties of polyphenolics may not fiiUy 
account for their chemopreventive effects. For example, it has been shown that 
although ellagic acid is an antioxidant ten times more potent than tannic acid, the 
latter was more effective in inhibiting skin tumor promotion than the former (Gali 
et al., 1992). In this study it was suggested that the antioxidant effects of these 
polyphenols may be essential but not sufficient for their antitumor promotion 
activity. E?q)ression of the bcl-2 proto-oncogene, which blocks apoptosis, 
decreases cellular ROS production (Kane et al., 1993), and the co-administration 
of antioxidant enzymes like superoxide dismutase or catalase prevents curcumin-
induced apoptosis in human leukemia cells (Jaruga et al., 1998). Properties of 
polyphenols such as binding and cleavage of DNA and the generation of ROS in 
the presence of transition metal ions are similar to those of certain known 
anticancer drugs (Ehrenfeld et al., 1987). Also, serum and tissue concentrations of 
copper are elevated in various malignancies (Linder, 1991; Margalioth et al., 
1983). It is well known that red wines are a rich source of resveratrol. Additionally, 
wines are also a good source of copper (Carmo, 1988; Darret et al., 1986). Further, 
it has been reported that inadequate dietary copper increases tumorigenesis in the 
MIN (Multiple intestinal neoplasia) mouse (Davis and Newman, 2000). It has also 
been recently shown that the programmed cell death induced by resveratrol in 
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THP-1 human monocytic leukemia cells is independent of Fas signaling pathway 
(Tsan et ai, 2000) suggesting the existence of pathways other than the 'classical'. 
The studies cited above suggest that prooxidant rather than the antioxidant 
properties of polyphenolic compounds may be responsible for the observed 
anticancer and apoptosis-inducing ability of these compounds. In view of this, I 
have studied the prooxidant macromolecular (DNA and protein) damage by 
resveratrol in the presence of copper ions. Specifically, I have studied i) oxidative 
DNA damage and protein fi-agmentation by resveratrol in the presence of copper 
ions and the mechanisms thereof and ii) mutagenicity of resveratrol in plasmid 
DNA. The DNA cleavage reaction catafyzed by resveratrol-Cu(II) is found to be 
biological^ relevant as assayed by bacteriophage inactivation. In the work 
presented in this thesis and published in Cancer Letters (Ahmad et al., 2000), 
evidence has been provided to suggest that resveratrol not only binds to copper 
ions but also is capable of redox cycling these ions. Based on these observations 
we have recently proposed a hypothesis (Hadi et al., 2000) for the anticancer and 
apoptosis-inducing properties of plant-derived polyphenolic compounds that 
involves mobilization of endogenous copper and the prooxidant action of these 
compo\mds. 
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Chemicals used for the present study were obtained 
Chemicals 
Aciylaniide 
Agar powder 
Agarose 
Ammonium persulphate 
Anpicillin hydrochloride 
Bathocuproine disu^hate 
Bovine serum albumin 
Catalase 
Chymotrypsin 
Deoxyribonucleic acid 
(Calf Thymus Type I) 
Dipbenylamine 
Ethidium Bromide 
Ethylenediaminetetraacetic acid (EDTA) 
Histidine 
Isopropyl-P-thiogalactopyranoside (IPTG) 
Lysozyme 
N, N'-Methylene bisacrylamide 
Nitroblue tetrazolium 
Nutrient broth 
p-nitroso dimethyl aniline 
Pepsin 
Plasmid Bluescript SK(+) 
Primer (Ml3 - forward) 
Primer (Ml3 - reverse) 
fra«5-Resveratrol 
Riboflavin 
from the following sources: 
Sources 
Sigma Chemical Co., USA 
Hi-Media, India 
Koch light Laboratories, 
England 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
BDH, India 
Sigma Chemical Co., USA 
Qualigens, India 
E. Merck, Germany 
Bangalore Genei, India 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sisco Research Labs, India 
Hi-Media, India 
Aldrich Chemical Co., USA 
Sigma Chemical Co., USA 
Mr. Sharik Rahil Khan, 
ICGEB, New Delhi 
PE Applied Biosystems, USA 
PE Applied Biosystems, USA 
Pharma Science Inc., Canada 
Sigma Chemical Co., USA 
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Single strand specific nuclease 
Sodium azide 
Sodiiun benzoate 
Sodium dodecyl sulphate 
Supercoiled pksmid pBR322 DNA 
Superoxide dismutase 
N,N,N',N',- Tetramethylethylenediamine 
(TEMED) 
Terminator ready reaction mix 
(for sequencing) 
Thiourea 
Trinitrobenzenesulphonic acid (TNBS) 
Tris(hydroxy methyl)aminomethane 
Triton X-100 
L-Tryptophan 
X-gal 
MATERIALS 
Sigma Chemical Co., USA 
Isolated and purified, from 
germinating pea seeds, in the 
lab according to the procedure 
ofWaniandHadi,1979 
E. Merck, Germany 
E. Merck, Germany 
Sigma Chemical Co., USA 
Isolated and purified in the lab 
according to the procedure of 
Sambrookera/. (1989) 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
PE Applied Biosystems, USA 
E. Merck, Germany 
Sigma Chemical Co., USA 
Fluka AG, Switzerland 
BDH, India 
Sigma Chemical Co., USA 
Bangalore Genei, India 
All other chemicals were commercial products of anahtical grade. 
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Media for E. coli strains 
Nutrient Broth (13.0 g/L) obtained from Hi-Media (India) had the foUowii^ 
components-
Peptone 
NaCl 
Beef extract 
Yeast extract 
pH (approx.) 
5.0 g/L 
5.0 g/L 
1.5 g/L 
1.5 g/L 
7.4±0.2 
Nutrient Agar (Hard Agar) 
Nutrient Broth 
Agar Powder 
13.0 g/L 
15.0 g/L 
Soft Agar/ Top Agar 
Nutrient Broth 
Agar Powder 
: 13.0 g/L 
7.0 g/L 
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Strain Designation 
AB1157 
Genetic Markers 
F, thr-l, ara-14, lenB6, A(gpt-
proA62), lac Yl, tsx33, qsi^ ", 
supE44, galK2, X rac", hisG4(0c), 
rfbD 1, Mgl-51, rpsL31, KdgK51, 
xyl-5, mtl-1, argE3(0c), thi-1 
Source 
Barbara J. Bachmann 
E. coli genetic stock 
centre. Department of 
Biology, 3550 ML 
Yale University, New 
Haven, CT, USA 
DH5a F end Al, hsdR17(rk- mk+), 
supE44, thi-1, recAl, gyrA96 
relAl, A (lacZYA-argFVI69), 
deoR,<t)-80AlacZAM15 
Sharik Rahil Khan 
ICGEB, 
New Delhi, India 
Strain of phage lambda used in this study was: 
A-vir Virulent strain, contains an absolute defective mutation in the immunity 
region and therefore forms clear plaques. 
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Sequencing materials 
The ABI PRISM Big Dye Terminator Ready Reaction Mix obtained jfrom Perkin-
Elmer Applied Biosystems (USA) had the following components: 
• A-Dye Terminator labeled with dichloro[R6G] 
• C-Dye Terminator labeled with dichloro[ROX] 
• G-Dye Terminator labeled with dichloro[Rl 10] 
" T-Dye Terminator labeled with dichloro[TAMRA] 
• Deoxynucleoside triphosphates (dATP, dCTP, dITP, dUTP) 
• Anq)liTaq DNA Polymerase, FS, with thermally stable 
pyrophosphatase 
• MgClz 
• Tris-HCl buffer, pH 9.0 
The primers obtained from Perkin-Etaoer Applied Biosystems (USA) were: 
M13 forward primer -^ 5'-GTAAAACGACG<JCCAGT-3' 
M13 reverse primer -^ 5'-GGAAACAGCTATGACCATG-3' 
Sequencing equipments 
• Perkin-Ehner Applied Biosystems ABI Prism® 377 DNA sequencer, with 
accessories 
• Perkin-Elmer Applied Biosystems Gene Amp® PCR System 9700 
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Reaction of resveratrol with calf thymus DNA and digestion with single 
strand-specific nuclease 
Resveratrol was dissolved in 3inM NaOH before use as a stock solution of ImM. 
Upon addition to reaction mixtures, in the presence of buffers and at the 
concentrations iised, resveratrol remained in solution. The volumes of stock 
sohitions added did not lead to any appreciable change in the pH of reaction 
mixtures. Reaction mixtures (0.5 ml) contained 10 mM Tris-HCl (pH 7,5), SOO^ ig 
of calf thymus DNA and varying amounts of resveratrol, cupric chloride and other 
metal ions. Bathocuproine or fi%e radical scavengers were inchided in some 
experiments. All solutions were sterilized before use. Incubation was performed at 
37^C for specified time periods. Single strand specific nuclease digestion was 
performed as described by Wani and Hadi (1979). The assay determines the acid 
soluble nucleotides released fix>m DNA as a result of enzymatic digestion. 
Reaction mbcture in a total volume of 1.0 ml contained 40 mM Tris-HCl (pH 7.5), 
1 mM magnesium chloride, water and aizyme. The reaction mixture was incubated 
at 37°C for 2 hours. The reaction was stopped by addii^ 0.2 ml of bovine serum 
albumin (10 mg/ml) and 1.0 ml of 14% perchloric acid (ice cold). The tubes were 
immediately transferred to 0°C for 45 minutes before centriftigation at 2500 rpm 
for 10 minutes at room ten^rature to remove the und^ested DNA and 
precipitated protein. Acid-soluble deoxyribonucleotides were determined in the 
supernatant, colorimetrically, using the diphenykmine method (Schneider, 1957). 
To a 1.0 ml aliquot, 2.0 ml dipl^nyl reagent (fi-eshly prepared by dissolving 1 gm 
of reciystallized diphenylamine in 100 ml of glacial acetic acid and 2.75 ml of 
concentrated H2SO4) was added. The tubes were heated in a boiling water bath for 
30 minutes. The intensity of blue colour was read at 600 nnt 
Treatment of supercoiled plasmid pBR322 DNA with different 
compounds in the presence of Cu(II) 
Reaction mixtures (30 \il) contained 10 mM Tris-HCl (pH 7.5), 0.50 i^g of plasmid 
DNA and other con^nents as indicated in the legends. Incubations were 
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performed at 3 /C for time periods specified in the legends. After incubation, 10 ^ 1 
of a solution containing 40 mM EDTA, 0.05% bromophenol blue tracking dye and 
50% (v/v) glycerol was added and the solution was subjected to electrophoresis in 
submarine 1% agarose gels. The gels were stained with ethidium bromide (0.5 
Hg/ml), viewed and photographed on a transilluminator. 
Absorption studies 
The absorption spectra were obtained by using Beckman DU-40 spectrophotometer 
(USA) equipped with a plotter. 
Spectrophotometric study for the reduction of Cu(II) to Cu(I) 
The selective Cu(I) sequestering agent, Bathocuproine, was used to detect 
reduction of Cu(II) to Cu(I) spectrophotometrically by recording the spectra 
between 350-550 nm. Bathocuproine conq)lexes with Cu(I) to form 
Cu(Bathocuproine)2^ complex which has an absorption peak at 480 nm and the 
molar extinction coefficient of the complex is 13,500 at this wavelength (Nebesar, 
1964). The reaction mixture (1.5 ml) contained 10 mM Tris-HCl (pH 7.5), 50 ^M 
resveratrol, 50 nM Cu(II) and 150 \iM Bathocuproine. The spectra were recorded 
immediately after the addition of all components. In a positive control, 25 ^M 
Cu(I) was added to bathocuproine. 
Stoichiometric titration of Cu(I) production 
The amount of Cu(I) produced in the drug-Cu(II) reaction mixture was determined 
by titration with bathocuproine. Resveratrol (5 |iM and 10 ^ M) in 10 mM Tris-HCl 
(pH 7.5) was mixed with varying concentrations of Cu(II) (CuCb) and 300 |iM 
bathocuproine, in a total volume of 1.5 mL Absorbance was recorded at 480 nm 
after 10 minutes of incubation at room temperature. 
Detection of superoxide anion (02'~) 
Superoxide was detected by the reduction of nitroblue tetrazolium (NBT) 
essentially as described by Nakayama et al. (1983). A typical assay mixture 
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contained 50 mM sodium phosphate buffer pH 8.0, 33 ^M NBT, 100 nM EDTA 
and 0.06% triton X-100 in a total volume of 3.0 ml. The reaction was started by the 
addition of resveratrol. After mixing, absorbance was recorded at 560 nm at 
different time intervals, against a blank which did not contain the compound. The 
rate of formazan production by increasing concentrations of resveratrol was also 
determined. To confirm the formation of superoxide anion, SOD was added to the 
solution, in a control tube, before addition of the compound. 
Singlet oxygen monitoring 
Singlet oxygen was measured by the method of Kraljic and Mohsni (1978) by 
detecting the bleaching of p-nitrosodimethylaniUne (pRNO) by resveratrol in the 
presence of histidine which serves as a selective acceptor of singlet oxygen. 
Histidine (33.3 |ag/ml) was added to the pRNO solution (prepared in 0.01 M 
phosphate buffer, pH 7.8). Irradiation by fluorescent light of the reaction mixture 
was performed for varying time periods of incubation. Singlet oxygen formed a 
transannular peroxide intermediate con:^ )lex with histidine leading to the bleaching 
of pRNO v^ch was measured spectrophotometrically at 440 nm. The generation 
of the singlet oxygen in the reaction system was further established by adding 
sodiiun azide to the reaction mixture (Joshi, 1985). Singlet ojQ'gen generation by 
riboflavin (Naseem, et ai, 1993) was used as a positive control. 
Assay of hydrogen peroxide (H2O2) production 
The production of hydrogen peroxide was assayed by the method of Nakayama et 
al. (1983) with modifications. Titanium sulphate [Ti(S04)] solution was prepared 
fi-om titanium dioxide (Snell and Snell, 1949) and diluted so that the final 
concentration was 1% (w/v) Ti(S04) in 1.25 M H2SO4. A 2.0 ml sample containing 
different amounts of resveratrol was mbced with 2.0 ml of 50 mM sodium 
phosphate buffer (pH 7.2) and incubated at room temperatiire for 1 hour. An 
aliquot of the mixture was added to 2.0 ml of a titanium sulfete solutioa A blank 
sanqile was also prepared which did not contain titanium sulfete and absorbance 
was recorded at 410 nm. Catalase (100 |Ag/ml) was added in a separate reaction 
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before incubation to confirm that the colour change was due to the generation of 
H2O2. 
Maintenance and growth of bacterial strains 
Each strain of E. coli was streaked on a nutrient agar plate. A single colony was 
picked up fiom the plate and repurified by streaking. The culture was tested on the 
basis of associated genetic markers; raising it fi-om a single colony on a master 
plate. Having been satisfied with the test clone, the culture was streaked on nutrient 
agar slants. It was then allowed to grow overnight at 37®C and thereafter stored at 
4°C. The cultures were transferred onto fi«sh slants every month. 
Preparation and maintenance of bacteriophage lambda 
Bacteriophage stocks were prepared on plates by confluent l^is method 
(Sambrook et ah, 1989). Bacteria fix)m the e?qponential culture were harvested and 
resuspended in 10 mM MgS04 sohitioa 0.3 ml of ABl 157 host cells was infected 
with phage lambda at a multq)licity of infection (nLo.l) of 5.0. Adsorption was 
allowed for 20 minutes at 37°C and plated with 3.0 ml of molten soft agar on hard 
agar plates. Plates were then incubated at 'i'fC till confluent lysis was visible to the 
naked eye. The top agar containing phage lambda was scraped in a 10 mM MgS04 
solutioiL 1% chloroform was then added and mixed by gentle vortexing at 37*C. 
Phage was obtained in the supernatant by centrifiigation of the above lysate at 
10,000 rpm for 20 minutes at 4°C. The phage stock thus obtained was titred and 
stored at A^C over few drops of chloroform. 
Assessment of bacteriophage lambda inactivation 
To assess bacteriophage inactivation, resveratrol and a stock of aqueous CuCla 
previously sterilized by filtration were added to a suspension (0.1 ml) of phage in 
Tris-HCVMg^ * (0.01 M each, pH 8.0). CuCk was added 10 minutes after the 
addition of resveratrol and the reaction mixture was incubated at 37°C for specific 
time periods during which it was vortexed at 5 minutes intervals. In some 
experiments the quenchers of reactive oxygen species or bathocuproine were added 
before the addition of CuCt. After incubation, treated phi^e was diluted with 10 
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mM MgS04 and 0.1 ml of dUuted phage was added to a 0.3 ml suspension of £. 
coli host strain. Lambda- E. coli conqjlexes were vortexed for 1 minute and then 
incubated for 20 minutes at 37"C. After incubation, 3.0 ml of soft agar (40°C) was 
added to the treated phage, vortexed and immediately poured on the nutrient agar 
plates. Plates were incubated at 3 /C for 5-6 hours followed by counting of plaque 
forming units (PFU). For each e}q)eriment, parallel control incubations were also 
performed. 
For ejqjeriments in which the indicator was pre-treated with UV light, cells were 
harvested, resuspended and washed 3 times by centriftigation in 0.15 M NaCl, 
0.015 M potassium phosphate buffer pH 7.5 and a final suspension (10*cells/ml.) 
was poured onto a petridish to a depth of 3 mm. The dish was e>qx>sed to an 
uncalil:n:ated 40 Watt UV lanp fix)m a distance of 20 cm. For e}q)erimental assays, 
the viability of the cells used for the assay was determined by dilution and plating 
on nutrient media. 
Fragmentation of proteins by resveratrol in the presence of Cu(II) 
The reaction mixture (1.0 ml) contained 10 mM potassium phosphate buffer (pH 
7.5), bovine serum albumin (2 mg/ml) and varying concentrations of resveratrol 
and Cu(II). In some experiments bathocuproine or scavengers of oxygen free 
radicals were added. The reactions were started by the addition of Cu(II). After 
incubation at 37°C for specified time intervals, the reactions were stopped by 
adding 1 mM EDTA and were precq)itated with 5% TCA. The tubes were 
immediately transferred to ice for 1 hour before centriftigation at 2000 rpm for 10 
minutes at room temperature to remove the imfragmented protein. The generation 
of material soluble in TCA was assessed by estimating fi«e amino groups using 
trinitrobenzenesulphonic acid (TNBS) (Snyder and Sobocinski, 1975). 25 jil of 30 
mM aqueous TNBS was added to 100 i^l of sanqjle and 1.0 ml of disodium tetra 
hydro borate buffer (pH 9.5), vortexed to ensure conq l^ete mixing and allowed to 
stand at room ten^rature for 30 minutes. The absorbance was read at 420 nm 
against a blank which consisted of 25 ^1 of 30 mM TNBS in 1.1 ml of borate 
buffer (pH 9.5). The reaction was calibrated with glycine and the princq)le of this 
40 
METHODS 
assay is the formation of highly absorbing (A420) chromophore of 
picrylsulphonamides formed by condensation of the reagent with free amino 
groups. The fragmentation products of BSA were also analyzed by SDS-
polyacrylamide gel electrophoresis as described by Laemmli (1970). Sanq)les were 
mixed with 5X sample loading buffer (125 mM Tris, 960 mM glycine, 0.1% SDS, 
pH 8.3) and heated at 90°C for 10 minutes before loading on 10% (w/v) acrylamide 
gel containing 0.1% SDS. To optimize the detection of any fragments formed 
during exposure of BSA to resveratrol-Cu(II), lanes were heavily loaded (10 ^g of 
BSA/lane) and the gel was visualized by a very sensitive staining procedure for 
visualizing proteins in polyacrylamide gels - silver staining (Blum et al., 1987). 
Fluorescence studies 
The fluorescence studies were performed on a Shimadzu spectrofluorophotometer 
RF-5000 (Japan) equipped with a calculator and a plotter. Resveratrol was excited 
at its absorption maximum (XnuuO of 308 nm (Jeandet et al, 1997) while L-
tryptophan and all the proteins were excited at 280 nm. Emission spectra were 
recorded in the range mentioned in the legends to figures. 
Fluorescence quench titration and determination of binding of 
resveratrol to proteins 
The fluorescence titration and the calculations of binding constant/binding capacity 
of resveratrol for proteins were performed exactly as described by Levine (1977). 
The titration consisted of adding aliquots of resveratrol to the tryptophan/proteins 
solutions and measuring the decrease in tryptophan fluorescence after each 
addition. In almost all the cases the region of interest was the 
resveratrol/(tryptophan/protein) ratio of 0 to 5.0. At least 40 points were obtained 
in the region of interest. The fluorescence quench curves were plotted with the 
molar ratio of resveratrol to tryptophan/protein on the abscissa and the 
fluorescence on the ordinate. Fractional quench (Q) was calculated from these 
curves by the relation -> Q = (Fo-F)/m, where F is the fluorescence at the molar 
ratio (resveratrol: tryptophan/protein) of 1, Fo is the fluorescence at zero ratio and 
m is the maximal quench of fluorescence. The fluorescence quench curves were 
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used to generate scatchard plots and an analysis of the scatchard plots was done as 
described by Steiner et al. (1966) to determine the binding constant and the 
number of moles of resveratrol bound per mole of tryptophan/protein. 
Preparation of competent cells 
Con^)etent cells were prepared l^ the method of Cohen et al. (1972) with slight 
modifications as described by Sambrook et al. (1989). A single colony of DH5a 
cells from the hard agar plate was inoculated in 10 ml of nutrient broth with 
nalidixic acid (final concentration - 50 fig/ml, dissolved in 50 mM KOH) and 
incubated at 'i'fC on a shaker for 6 hours. One ml inocuhim from this culture was 
then used to inoculate 100 ml of nutrient broth and this was again incubated at 
37°C on a shaker. When the O.D.600 of the culture reached a value of 0.3-0.4, the 
culture was chilled at 4°C for 45 minutes and subsequently centrifriged at 5000 rpm 
for 10 minutes at 4°C. The pellet was resuspended in 25 ml of 0.1 M CaCt and 
incubated at 4°C for 30 minutes before centrifugation at 5000 rpm for 10 minutes 
at 4^C. The pellet was now suspended in 4 ml of 0.1 M CaCb and kept on ice for 
12 hours. Thereafter, gfycerol (15% final concentration) was added and the cells 
were stored at -80°C in aliquots of 0.5 ml. 
Treatment of plasmid DNA with resveratrol and transformation in 
competent DH5a cells 
Plasmid Bluescript SK(+) DNA carries a short segment of E. coli DNA that 
contains the regulatory sequences and coding information for the first 146 amino 
acids of the P-galactosidase gene {lacZ) (Short et a/., 1988). Embedded in the 
coding region is a polycloning site that does not disrupt the reading fi-ame but 
results in the harmless interpolation of a small number of amino acids into the 
amino terminal fragment of p-galactosidase. Vectors of this type are used in host 
cells (such as DH5 a) that code for the carboxy terminal portion of the P-
galactosidase. Although neither the host-coded nor the plasmid-coded fi-agments 
are themselves active, they can associate to form an enzymatically active protein. 
This type of complementation, in viiich deletion mutants of the operator-proximal 
segment of the lacZ gene are conqjlemented by P-galactosidase-negative mutants 
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that have the operator-proximal region intact, is called a-complementation 
(Ullmaim et al, 1967). The Lac^ bacteria that result from a-con^lementation are 
easily recognized because they form blue colonies in the presence of the 
chromogenic substrate 5-bromo-4-chloro-3-indolyl-P-D-galactoside pC-gal) 
(Horwitz et al., 1964). However, mutation in the lacZ part of the plasmid almost 
invariably results in production of an amino terminal fragment that is not capable 
of a-complementation-
Plasmid Bhiescript SK(+) DNA (-lOOng) in Tris-HCl buffer (0.1 M, pH 7.5) was 
treated with different concentrations of resveratrol in the presence of 50 i^M Cu(II) 
in a final volume of 50 i^l at 37°C for 2 hours. The treated plasmid DNA was 
incubated with 0.1 ml of competent DH5a cells at 4°C for 30 minutes followed by 
a 2-minute heat shock at 42°C. Nutrient lax)th (1.0 ml) was added and the cells 
were incubated at 37*'C for 1 hour for the expression of antibiotic resistance. 
Transformed cells were plated on LB plates containing 60 |xg/ml an^icillin, 40 \i\ 
X-gal (dissolved in dimetlQ l^formamide) and 40 JAI IPTG. The plates were 
incubated overnight at 37^C followed by 4 hours of incubation at 4°C to allow the 
bhie colour to develop fiilly. Colonies was than counted to score the number of 
mutants ( \^iute colonies) vs. the number of normal colonies (blue colonies). 
Isolation of plasmid DNA from mutants 
Plasmid DNA isolation was performed by the method of Birboim and Doly (1979) 
as described by Sambrook et al. (1989). Firstly, small-scale preparation (mini-
prep) was carried out. Overnight grown bacterial cells (1.5 ml) were pelleted by 
centrifiigation at 12000 rpm for 30 seconds at 4°C. Pellet was resuspended in 200 
\i\ of Solution I (50 mM glucose, 25 mM Tris-HCl pH 8.0 and 10 mM EDTA pH 
8.0). To this, 200 |xl of freshfy prepared alkaline lysis solution - Solution II (0.2 N 
NaOH and 1% SDS - final concentration) was added which was mixed by 
inverting several times and then incubated at room ten:q)erature for 10 minutes. 
Thereafter, 300 ^1 of Solution III (3M potassium acetate*, 5 M acetate", pH 4.8) 
was added and mixed thoroughly by vortexing in inverted position. The eppendorf 
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was transferred to ice for 15 minutes before centrifUgation at 12000 rpm for 15 
minutes at 4°C. 0.6 volume of iso-propanol was then added, allowed to stand for 5 
minutes at room ten^)erature and plasmid DNA was precipitated by centrifiigation 
at 10000 rpm for 20 minutes at room ten^rature. Presence of plasmid DNA was 
checked by electrophoresis on 1% agarose gels. Once the presence of plasmid 
DNA was confirmed, large-scale preparation of the plasmid (maxi-prep) was done. 
For this, overnight grown bacterial cells (500 ml) were pelleted by centrifiigation at 
5000 rpm for 10 minutes at 4"C. Pellet was resuspended in 20 ml of Solution I 
containii^ 5 mg/ml freshly prepared lysossyme and kept on ice for 15 minutes. To 
this, 40 ml of freshly prepared Solution 11 was added, mixed by inverting several 
times and then incubated at room temperature for 20 minutes. Finally, 30 ml of 
Solution III was added and mixed thoroughly by vortexing in inverted position. 
The tube was then transferred to ice for 30 minutes before centrifiigation at 9000 
rpm for 15 minutes at 4°C. Cheesecloth was used to obtain the filtrate and 0.6 
volume of iso-propanol was then added to filtrate. This was mixed well and 
allowed to stand for 10 minutes at room tenq)erature and plasmid DNA was 
recovered by centrifiigation at 9000 rpm for 20 minutes at room ten^rature. To 
remove contaminating RNA, DNase-fi«e pancreatic RNase was added to a final 
concentration of 10 i^g/ml and incubated at room temperature for 1 hour. 
Sequencing of mutants 
The sequencing of mutant plasmid DNA was done enq>loying the basic 
dideoxynucleotide nwdiated chain terminating method of Sanger et al. (1977). 
Sequencing was carried out on a PE Applied Biosystems ABI Prism®377 
automated DNA sequencer which uses fluorescent dye-tagged terminator 
dideoxynucleotides. In a total volume of 10 |nl, 1.0 ^1 of plasmid DNA (-500 ng) 
was mixed with 4.0 ^1 of terminator ready reaction mix and 5 pmole of primer. 
Cycle sequencing was done for an^lifying the desired region in plasmid DNA by 
PCR. The primer used (Ml 3 reverse) flanked our region of interest le. lacZ gene. 
Ml3 forward primer was also used to confirm the results. PCR was programmed to 
run for a total of 30 cycles with each cycle consisting of three steps: 96"C-20 
seconds (denaturation step), 50°C-30 seconds (annealing step) and 60°C-4 minutes 
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(extension step). The PCR products were concentrated by the addition of 25 i^l of a 
solution containing 3 mM sodiiun acetate, pH 4.8 and absolute ethanol, before 
centrifugation at 10000 rpm for 10 minutes. Pellet was washed with 20 \il of 70% 
ethanol and recovered by centrifugation at 10000 rpm for 10 minutes. After 
allowing the pellet to dry, 4 )il of sequencing dye containing 16.67% blue dextran 
and 83.33% formamide was added. This was heat denatured at 95°C for 5 minutes 
before loading (1.5 |xl) on a 5% polyacrylamide sequencing gel. 
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Breakage of calf thymus DNA by resveratrol in the presence of Cu(II) 
Resveratrol in the presence of Cu(II) was found to generate single strand specific 
nuclease sensitive sites in calf thymus DNA. The reaction was assessed by 
recording the proportion of DNA converted to acid-soluble nucleotides by the 
nuclease. Figure 3 gives the kinetics of such a reaction. Control e:q)erinients (data 
not shown) established that heat denatured DNA underwent 100% hydrolysis 
following the treatment with nuclease. In the presence of Cu(II) (50nM), 
increasing concentrations of resveratrol resufted in a increase in calf thymus DNA-
nuclease sensitive sites (Figure 3A). A similar increase in DNA hydrofysis was 
observed when either Cu(II) concentration was increased keeping resveratrol 
constant (50^M) (Figure 3B) or -wbsii the time of incubation of the reaction was 
increased with resveratrol and Cu(n) concentrations being kept constant (50^M 
each) (Figure 3C). 
Cleavage of plasmid pBR322 DNA 
In order to substantiate the above results, supercoiled pBR322 DNA was examined 
as a substrate as the relaxation of such a molecule is a sensitive test for just one 
nick per molecule which results in its conversion to the open circular form. 
Resveratrol, at all the concentrations tested (25 iiM, 50 ^M and 100 fiM), 
converted supercoiled DNA to relaxed open circles in the presence of 100 |iM 
Cu(II) (Figure 4). This reaction was found to be dose-dependent as, at towest 
resveratrol concentration, all the supercoiled plasmid DNA was converted to open 
circular form and with progressively higher resveratrol concentrations, the linear 
form of the plasmid also appeared. Neither 100 pM resveratrol alone (lane b) nor 
100 \xM Cu(II) (lane c) alone was found to cleave plasmid DNA. 
In addition to Cu(II), several other transition metal ions [Co(II), Fe(II), Mn(II), 
Mg(II) and Ni(II)] were tested for their ability to conplement resveratrol in the 
plasmid DNA cleavage reaction. As apparent fi-om Figure 5, only Cu(II) 
complemented resveratrol in such a reaction and there was no indication of any 
cleavage of plasmid DNA in the presence of the other metal ions. 
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Figure 3; Kinetics of degradation of calf thymus DNA by resveratrol in the 
presence of Cu(II) as measured by the degree of single strand specific 
nuclease digestion. 
500 ng calf thymus DNA was incubated at 37°C with mdicated concentrations of 
resveratrol and Cu(II) in a total reaction volume of 0.5 ml containing 10 mM Tris-HCl 
(pH7.5). 
(A) Effect of increasing concentrations of resveratrol in the presence of 50 |JM CU(II) 
after 2 hours of incubation. (B) Effect of increasing Cu(II) concentrations in the 
presence of 50 pM resveratrol after 2 hours of incubation. (C) Effect of increasing 
times of incubation in the presence of resveratrol and Cu(II) (50 ^M each). Single 
strand specific nuclease digestion was performed as described in "Methods". All 
points represent triplicate samples and mean values have been plotted. 
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Figure 4: y^arose gel electrophoretic pattern of ethidium bromide stained 
pBR322 DNA after treatment with increasing concentrations of 
resveratrol in tiie presence of Cu(II). 
The reaction mixtures (30 i^l) contained 0.50 \xg pBR322 DNA, 10 mM Tris-HCl (pH 
7.5), 100 jiM Cu(II) and increasing concentrations of resveratrol. Incubation was 
carried out at 37°C for 1 hour. Lane a: plasmid alone, Lane b: plasmid + 100 (JM 
resveratrol, Lane c: plasmid + Cu(II), Lanes d - f: [plasmid + Cu(II)] + 25 pM, 50 ^M 
and 100 ^M resveratrol respectively. 
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Figure 5; Agarose gel electrophoretic pattern of ethidium bromide stained 
pBR322 DNA after treatment with increasing concentrations of 
resveratrol in the presence of different metal ions. 
The reaction mixtures (30 |il) contained 0.50 |ag pBR322 DNA, 10 mM Tris-HCl (pH 
7.5), 200 |JM resveratrol and 100 foM metal ions. Incubation was carried out at 37°C 
for 1 hour. Lane a: plasmid alone, Lanes b-g: [plasmid + resveratrol] + Cu(II), Co(lI), 
Fe(II), Mn(II), Mg(ll) and Ni(ir) respectively. Lane h: plasmid + resveratrol. 
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Reduction of Cu(II) to Cu(I) 
To determine whether resveratrol-Cu(II) interaction results in the reduction of 
Cu(II) to Cu(I), bathocuproine was used as an agent that sequesters Cu(I) 
selectively. Bathocuproine forms an intense orange con^lex with Cu(I) and this 
Cu(I) chelate of bathocuproine has an absorption maximum at 480 nm. Under the 
e}q)erimental conditions, neither Cu(II) nor resveratrol interfered with this 
absorption ny^ ximum, whereas resveratrol reacted with Cu(II) to generate Cu(I) 
leading to the formation of characteristic complex with bathocuproine (Figure 6). 
The reaction possibly leads to the formation of 'oxidized species' of resveratrol as 
in the case of other polyphenolic con^unds such as flavonoids (Rahman et al., 
1990; Utaka and Takeda, 1985). The implication of these findings is that Cu(ll) is 
reduced by resveratrol although the sequestering of Cu(I) by the reagent does not 
establish v^iether Cu(I) is an end-product or an intermediate in the reaction that 
occurs in the absence of sequestering compound. 
Stoichiometiy of Cu(I) production 
To determine the stoichiometry of the reduction of Cu(Il) by resveratrol, the 
experiment shown in Figure 7 was performed. Increasing concentrations of Cu(II) 
were added to a fixed concentration of resveratrol (5 jiM / 10 ^M) and the results 
are plotted as O.D. at 480 nm Vs. equivalents of Cu(II)/resveratrol (Figure 7A). No 
clear maximum, where absorption plateaued, was obtained suggesting a possible 
recycling of copper ions in the reaction. The data was also utilized to calculate the 
amount of Cu(I) produced at each concentration of Cu(II) added and this is shown 
in Table 1. Also, increasing concentrations of resveratrol were added to a fixed 
concentration (10 ^M) of Cu(II) (Figure 7B). Again no clear absorption maximum 
plateau was observed. These results suggest that the oxidized species of resveratrol 
are also able to catalyze the reduction of recycled copper ions [Cu(II)]. 
Involvement of Cu(I) in the reaction 
Interaction of resveratrol with Cu(II) leads to the production of Cu(I). It was, 
therefore, of interest to ascertain the in^rtance of production of Cu(l) with 
relation to DNA degradatioa For this purpose, bathocuproine was added to the 
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Fieure 6: Detection of resveratrol-induced Cu(I) production by bathocuproine. 
The 1.5 ml reaction mixtures contained 10 mM Tris-HCl (pH 7.5), 50 ^M resveratrol, 
50 ^M Cu(II), 25 ^M Cu(l) and 150 nM bathocuproine. The spectra (350 nm - 550 
nm) were recorded immediately after the addition of components indicated. 
(_••••_) • Bathocuproine + 50 nM resveratrol + 50 |iM Cu(II) 
( ) : Bathocuproine + 25 ^M Cu(I) 
( _•_•_) : Bathocuproine + 50 |aM Cu(II) 
( ) : Bathocuproine + 50 ^M resveratrol 
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Figure 7: Detection of stoichiometry of resveratrol and Cu(II) interaction. 
Reaction mixtures contained 10 mM Tris-HCl (pH 7.5) and indicated amounts of 
resveratrol, Cu(II) and bathocuproine. Absorbance was recorded after incubating the 
reaction mixtures at room temperature for 10 minutes. 
(A) The difference in absorbance at 480nm of samples with and without added Cu(II) 
is plotted versus equivalents of Cu(II) per molar equivalent of resveratrol. 
Concentrations of resveratrol used were (•) 5 |jMand (O) 10 [xM. (B) The difference 
in absorbance at 480nm of samples with and without added resveratrol is plotted 
versus equivalents of resveratrol per molar equivalent of Cu(ir)- Concentration of 
Cu(II) was 10 [\M. Concentration of bathocuproine used was 300 joM in all cases. All 
the points represent triplicate samples and mean values have been plotted. 
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Table I: Quantitation of Cu(I) produced on addition of increasing amounts of 
Cu(II), as determined by stoichiometric anatysis. 
Cu(II) added 
0 
2.5 
5.0 
7.5 
10.0 
15 
20 
25 
30 
35 
40 
50 
60 
70 
80 
100 
120 
Cu(I) produced (^M) by 
5 nM resveratrol 
0 
3.2 
5.44 
ND 
7.5 
9.48 
10.6 
•" 11.26 
11.55 
12.6 
12.8 
13.44 
13.8 
ND 
ND 
ND 
ND 
10 fxM resveratrol 
0 
2.66 
5.33 
7.77 
9.07 
10.66 
11.88 
ND 
13.26 
ND 
14.81 
15.37 
16.41 
17.26 
17.26 
18.66 
19.41 
ND - Not Determined 
>/Acc. I ^ ) ^ I 
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reaction mixture to investigate whether sequestration of Cu(I) inhibited DNA 
breakage as assayed by single strand specific nuclease. In control experiments, the 
bathocuproine-Cu(I) complex was shown not to generate breaks, confirming the 
literature data (Wong et al., 1984). Effect of increasing concentrations of 
bathocuproine on resveratrol-Cu(II) reaction was determined by measuring percent 
DNA hydrolyzed in the absence of bathocuproine (A) and the percent hydrolysis in 
its presence (B). The percent inhibition [100x(A-B)/A] plateaued at a 
bathocuproine/Cu(II) ratio of 2 (Figure 8) confirming that Cu(I) is an essential 
intermediate and consistent with a s\rap\& sequestration mechanism for inhibition 
as the stoichiometry of the bathocuproine-Cu(I) conplex is 2:1. This result was 
confirmed by studying the effect of increasing concentrations of bathocuproine on 
resveratrol-Cu(II) mediated plasmid Bhiescript SK(+) DNA cleavage. As seen in 
Figure 9, treatment of plasmid with 200 i^M resveratrol and 100 i^M Cu(II) for 2 
hours at 37^ C resulted in a total degradation of the plasmid (lane b). However, 
progressive addition of bathocuproine resulted in inhibition of this degradation and 
at a concentration of 200 jiM bathociq>roine [twice that of Cu(II)], a total inhibition 
of the plasmid cleavage was observed (lane f). 
Formation of resveratrol-Cu(n) complex 
As Cu(II) is reduced to Cu(I) by resveratrol, there is a possibility for the formation 
of a resveratrol-Cu(II) complex. This was confirmed by recording the absorption 
spectrum of resveratrol with increasing concentrations of Cu(II). The results given 
in Figure 10 show that the addition of Cu(II) to resveratrol results in a shift in the 
Ximx of resveratrol towards the lower wavelength with a peak emerging at 274nm 
presumably representing one or more oxidized species of resveratrol. The structure 
of these oxidized products is not ascertained. As mentioned earlier, the oxidized 
products of resveratrol are possibfy also capable of reducing recycled Cu(II) to 
Cu(I). In such a case increased copper concentrations at a fixed concentration of 
resveratrol should result in increased rate of DNA hydrolysis. As shown in Figure 
11, this is indeed found to be the case. It is seen that wlien calf thymus DNA was 
treated with increasing Cu(II)/resveratrol molar ratios (0.5, 1 and 4), a concomitant 
enhancement in the DNA cleaving efficiency was observed. These results are 
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Figure 9: Inhibition by bathocuproine of resveratrol-Cu(II) mediated breakage 
of plasmid DNA. 
The reaction mixtures (30 pJ) contained 0.50 jig plasmid Bluescript DNA, 10 mM 
Tris-HCl (pH 7.5), 200 |iM resveratrol, 100 |JM CU(II) and increasing concentrations 
of bathocuproine. Incubation was carried out at 37°C for 2 hours. Lane a: plasmid 
alone. Lane b: plasmid + resveratrol + Cu(Tr), Lanes c-h: lane b + 50 |j.M, 100 |aM, 
150 i^M, 200 ^M, 300 ^M and 400 nM bathocuproine respectively. 
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Figure 10: Detecrion of resveratrol-Cu(n) complex. 
The 1.5 ml reaction mixtures contained 10 mM Tris-HCl (pH 7.5), 50 fiM resveratrol 
and increasing amounts of Cu(II). The spectra (250 nm - 450 nm) were recorded after 
he addition of components indicated. 
) : resveratrol alone 
_ ) : resveratrol + 50 i^M CuQl) 
_._.) : resveratrol + 100 ^M Cu(II) 
....) : resveratrol + 200 nM Cu(ll). 
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Figure 11: Effect of different Cu(n)/resveratroI molar ratios on calf thymus DNA 
degradation. 
500 i^g calf thymus DNA was treated with (•) 0.5:1; (A) 1:1 and (•) 4:1 Cu(n) / 
resveratrol molar ratios at 37°C for diflferent time intervals in a total volume of 0.5 ml 
containing 10 mM Tris-HCl (pH 7.5). Resveratrol concentration was 50 )iM in all the 
cases. Single strand specific nuclease digestion was performed as described in 
"Methods". All the points represent triplicate samples and mean values have been 
plotted. 
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therefore indicative of redox recycling of copper ions by 'oxidized species' of 
resveratrol. 
Changes in the absorption spectrum of resveratrol by visible light 
Resveratrol exhibits maximal absorption at 308 nm (Jeandet et al, 1997). It is a 
light sensitive compound and seems to undergoes a photosensitization reaction on 
exposure to ordinary light, possibly auto-oxidation and the absorption spectrum 
shows a quenching effect leading to a decrease in the intensity of the band at 308 
nm (Figure 12). Also, a very small shift in the absorption maximum towards a 
lower wavelength is observed after 1 hour of exposure to light. Thus, it is apparent 
that the changes in absorption spectrum of resveratrol on addition of Cu(II) such as 
those observed in Figure 10 are due to the formation of a complex with Cu(II) as 
the changes in absorption spectrum of resveratrol alone with time (Figure 12) are 
qualitatively different. 
Involvement of oxygen free radicals in the reaction 
Several mutagens of dietary importance such as flavonoids (Rahman et al., 1989) 
and tannic acid (Bhat and Hadi, 1994), anticancer drugs such as bleomycin 
(Ehrenfeld et al, 1987), adriamycin (Eliot et al., 1984; Haidle and McKinney, 
1985) and various other drugs have been shown to degrade DNA in the presence of 
a metal ion and molecular oxygen. In all these reactions active oxygen species 
were shown to be the proximal DNA cleaving agents. For this purpose, the effect 
of several known free radical scavengers on calf thymus DNA degradation by 
resveratrol in the presence of Cu(II) was examined. This reaction was found to be 
inhibited to different extents by various scavengers (Table II). Superoxide 
dismutase and catalase remove superoxide and H2O2, respectively. Sodium azide is 
a scavenger of singlet oxygen and sodium benzoate and thiourea remove the 
hydroxy! radical. Catalase caused the maximum inhibition of DNA breakage. From 
the data we conclude that H2O2 is an essential component in a pathway that leads 
to reactive oxygen species of which superoxide anion and singlet oxygen are 
alternate proximal DNA-breakage agents. 
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Figure 12: Effect of time on the absorption spectrum of resveratroL 
The concentration of resveratrol in a total of 1.5 ml reaction mixture containing 10 
mM Tris-HCl (pH 7.5) was 75 (iM. Traces, from top to bottom, are those taken after 0 
time, 30 minutes and 1 hour of incubation at room temperature in ordinary room light. 
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Table II; Percent inhibition of single strand specific nuclease hydrolysis of calf 
thymus DNA after treatment with resveratrol (100 }xM) and Cu(II) 
(50 nM) in the presence of scavengers of ROS. 
Conditions 
Catalase(100ng/ml) 
Boiled catalase (lOO^g/ml) 
Sodium Azide (50mM) 
Sodium Benzoate (50mM) 
Thiourea (50mM) 
SOD (lOO^g/ml) 
Inhibition (%) 
87.97 ± 2.05 
26.04 ± 0.78 
66.01 ±2.96 
32.02 ± 0.65 
0 
36.03 ± 2.69 
SOD - Superoxide Dismutase 
All values are expressed as Mean ± SE for three difiFerent experiments. 
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The involvement of oxygen free radicals in the resveratrol-Cu(II) mediated DNA 
cleavage was further substantiated by studying the effect of above mentioned free 
radical scavengers on plasmid Bluescript SK(+) DNA degradation (Figure 13). The 
results corroborated the above findings as maximum protection to plasmid DNA 
was afforded by catalase followed by sodium azide and SOD. Scavengers of 
hydroxyl radical were, however, seen to be ineffective. Taken together, the results 
of Table II and Figure 13 underline the inportance of hydrogen peroxide in the 
DNA cleavage reaction by resveratrol in the presence of Cu(II). Also, thiourea, a 
very potent scavenger of hydroxyl radicals was found to be ineffective. These 
results, therefore, support the findings of Fukuhara and Miyata (1998) who have 
proposed that Cu(Il) dependent DNA damage by resveratrol is caused 
predominantly by a copper-peroxide complex rather than by a freely difEiisible 
oxygen species. 
Generation of oxygen free radicals by resveratrol 
In view of the results with scavengers of reactive oxygen species, the ability of 
resveratrol to generate oxygen free radicals namely hydrogen peroxide, singlet 
oxygen and superoxide anion was studied. 
Generation of hydrogen peroxide 
The hydrogen peroxide production capacity of resveratrol was directly assayed by 
the method of Nakayama et al. (1983). The method involves oxidation of titanium 
to pertitanic acid by hydrogen peroxide. The formation of hydrogen peroxide was 
found to increase with increasing concentrations of resveratrol (Figure 14) and the 
reaction was significantly inhibited in the presence of catalase (100 ^ig/ml), 
confirming that the procedure genuinely measures hydrogen peroxide. 
Singlet oxygen production 
Singlet oxygen production was determined, as described by Kraljic and Mohsni 
(1978). Resveratrol was found to generate singlet oxygen in the presence of 
fluorescent light (Figure 15). This was tested by bleaching of pRNO in the 
presence of histidine, which serves as a selective acceptor of singlet oxygen. The 
64 
RESULTS-I 
Figure 13: Effect of various scavengers of ROS on resveratrol-Cu(II) mediated 
breakage of piasmid DNA. 
The reaction mixtures (30 ^1) contained 0.50 ^g piasmid Bluescript DNA, 10 mM 
Tris-HCl (pH 7.5), 200 ^M resveratrol, 100 foM Cu(II) and indicated amounts of 
scavengers. Incubation was carried out at 37°C for 2 hours. Lane a: piasmid alone, 
Lane b: piasmid + resveratrol + Cu(ll), Lanes c-g: lane b + 100 |xg / ml catalase, 100 
\xg I ml SOD, 50 mM thiourea, 50 mM sodium azide and 50 mM sodium benzoate 
respectively. 
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Figure 14; Generation of hydrogen peroxide by increasing concentrations of 
resverafa*oL 
(•) : resveratrol 
(O) : resveratrol + 100 i^g/ml catalase 
A detailed procedure is given in "Methods". All the points represent triplicate samples 
and mean values have been plotted. 
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Figure 15: Singlet oxygen production by resveratrol under fluorescent light. 
Generation of singlet oxygen was measured by recording decrease in the absorption of 
p-nitrosodimethylaniline (pRNO) solution (30 i^M in 10 mM potassium phosphate 
buffer, pH 8.0) containing 10 mM histidine as a selective acceptor of singlet oxygen. 
Concentration of resveratrol and Cu(II) was 100 pM each in all the cases. 
(D) 
(•) 
( • ) 
(•) 
pRNO alone 
pRNO + resveratrol + Cu(II) + 50 mM sodium azide 
pRNO + resveratrol + Cu(II) 
pRNO + 1.5 |j.g/ml riboflavin. 
All the points represent triplicate samples and mean values have been plotted. 
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bleaching of pRNO by resveratrol-Cu(II) system was compared with the known 
producer of singlet oxygen namely, riboflavin. It is observed that although the 
bleaching of pRNO by 100 ^M resveratrol in the presence of 100 ^M Cu(II) was 
less than that observed with 1.5 ng/ml riboflavin, it was significant enough to 
establish the production of singlet oxygen. That the method assays singlet oxygen 
was confirmed by inhibition of the bleaching of pRNO by sodium azide. 
Superoxide production 
The production of superoxide anion was also determined by the method of 
Nakayama et al. (1983) which involved reduction of NBT by resveratrol to 
formazan (Table III). The time-dependent generation of superoxide anion by 100 
^M resveratrol, as evidenced by the increase in absorbance at 560 nm, is shown in 
Figure 16. The fact that NBT was genuinely assaying superoxide was confirmed by 
SOD (100 ^g/ml) inhibiting the reaction. 
Effect of resveratrol-Cu(II) on the viability of phage X 
In order to explore the biological consequence of the DNA breakage reaction, 
inactivation of phage X by the resveratrol-Cu(II) system was tested. The 
inactivating activity was determined by incubating the phage with resveratrol-
Cu(II) and then measuring the loss of biological activity (Figure 17). Figiire 17A 
gives the loss of survival of phage as a fiinction of the resveratrol concentration. 
Increasing concentrations of resveratrol at a fixed concentration (50 ^M) of Cu(II), 
after an hour of incubation at 37°C, resulted in a progressive loss of survival of the 
phage. The percentage of phage surviving at the highest concentration of 
resveratrol tested (200 |J.M) was 11.7%. Increasing concentrations of Cu(II) with a 
fixed resveratrol concentration (50 nM), afler 1 hour of incubation at 37*^ C, also 
resulted in a similar loss of survival of the phage (Figure 17B). The percentage of 
phage surviving at the highest concentration of Cu(II) tested (200 ^M) was 36.9%. 
To determine the mechanism of phage inactivation by resveratrol-Cu(II), I studied 
the effects of bathocuproine and oxygen radical scavengers. The ph^e inactivation 
by resveratrol (100 \M) in the presence of Cu(II) (50 \M) was inhibited by 
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Table HI: Rate of production of superoxide anion from the solution of 
resveratrol as assayed by reduction of nitroblue tetrazoiium to 
formazan. 
Resveratrol concentration 
(HM) 
5 
10-
15 
20 
40 
60 
80 
100 
100 [+SOD(100ng/ml)] 
Formazan produced 
(HM) 
0.133 
0.400 
0.866 
1.133 
2.466 
3.666 
5.330 
7.260 
2.800 
SOD - Superoxide Dismutase 
All values are ejq)ressed as Mean ± SE for three different experiments. 
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Figure 16: Photogeneration of superoxide anion by resveratrol as a function of 
time. 
(•) : 100 ^ M resveratrol under fluorescent light 
(O) : 100 nM resveratrol + 100 ^ g/ml SOD 
A detailed procedure is given in "Methods". All the points represent triplicate samples 
and mean values have been plotted. 
70 
Time (Minutes) 
RESULTS-I 
Figure 17; Kinetics of lambda piiage inactivation by resveratrol-Cu(n). 
Phage was treated with indicated concentrations of resveratrol and Cu(II) at 37°C for 1 
hour in a reaction mixture containing 10 mM Tris-HCI/Mg^* (pH 8.0). 
(A) Effect of increasing concentrations of resveratrol in the presence of 50 pM Cu(II). 
(B) Effect of increasing Cu(II) concentrations in the presence of 50 i^M resveratrol A 
detailed procedure is given in "Methods". All the points represent triplicate samples 
and mean values have been plotted. 
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increasing concentrations of bathocuproine to more than 90% indicating the 
essential involvement of Cu(I) in the reaction (Figure 18). Further, the inhibition of 
phage inactivation plateaued at the bathocuproine: Cu(II) molar ratio of 2, thus, 
confirming the results of Figures 8 and 9. Bathocuproine is a chelator that 
sequesters Cu(I) in a form that is in«q)able of oxidation or reduction. This result 
therefore indicates that the formation of Cu(I) by resveratrol is an essential step in 
the phage inactivation mechanism. The inactivating activity of resveratrol-Cu(II) 
was substantial^ but diflferentialfy reduced by prior addition of quenchers of 
oxygen ftee radicals (Table IV). Ag£un, maximum inhibition was afforded by 
catalase followed by sodium azide and SOD indicating the involvement of 
hydrogen peroxide, singlet OTQ^gen and superoxide anion in the lambda phage 
inactivation reaction by resveratroL It is worth mentioning that inhibition by 
various quenchers correlates well with that observed in the case of calf thymus 
DNA degradation (Table II). 
Table V shows the sensitivity of bacteriophage k to resveratrol-Cu(II) and the 
effect of UV irradiation on the host cells. Control incubations of phage with 
lOOfiM resveratrol alone or 50^M Cu(II) alone resulted in < 5% inactivation. The 
fi-actions of surviving phage, after resveratrol-Cu(II) treatment, were 0.22 and 0.42 
in the case of untreated and UV treated host cells, respectively. It may be noted 
that at lOO^M resveratrol concentration used in this experiment, the flection of 
phage survival (0.22) matches the degree of inactivation in Figure 17A (0.24). This 
result indicates that UV treatment of the host bacteria enhances the recovery of the 
phage. One possibility could be that the UV inducible pathway is activated on such 
treatnwnt leadii^ to enhanced recovery of the phage. 
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Figure 18; Effect of increasing concentrations of bathocuproine on tlie viability of 
resveratrol-Cu(II) treated phage lambda. 
The concentrations of resveratrol and Cu(II) were 100 pM and 50 |JM respectively. 
Other details of the procedure are given in "Methods". All the points represent 
triplicate samples and mean values have been plotted. 
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Table IV: Percent inhibition of X inactivation after treatment with resveratrol 
(lOOuM) and Cu(II) (50 jxM) in the presence of scavengers of ROS. 
Conditions 
Catalase (lOOng/ml) 
Boiled catalase (lOOfxg/ml) 
Sodium Azide (50mM) 
Sodium Benzoate (50mM) 
Thiourea (50mM) 
SOD (lOOng/ml) 
% inhibition of X- inactivation 
78.57 ±3.08 
0 
50.89 ±1.33 
26.79 ±0.96 
4.89 ±0.15 
37.5 ±0.70 
SOD - Superoxide Dismutase 
All values are expressed as Mean ± SE for three different experiments. 
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The major conclusions of the experiments described in this chapter are: 
i) resveratrol is able to induce strand scission in calf thymus DNA and plasmid 
DNA, ii) it forms a complex with Cu(II) reducing it to Cu(I) which is an essential 
intermediate in the DNA cleavage reactioa In the process 'oxidized species' of 
resveratrol are generated which also appear capable of reducing Cu(II), iii) redox 
cycling of copper leads to generation of various reactive oxygen species, 
particularly hydrogen peroxide, singlet oxygen, and superoxide anion, \^iiich'^^^e 
as proximal DNA cleaving agents and iv) the reaction is biologicd^^6^ant'^ 
evidenced by bacterioph^e X, inactivation. ( * ( \ -f'-^  O < 
> , A L C . NV) 
These results place resveratrol in a class of plant-derived polypb t^ii^ bt^ HtJQxidants^ 
such as flavonoids (Ahmad et al., 1992) and tannins (Bbat and Hadi, 1^94^rdi£K^ 
also exhibit prooxidant DNA damaging properties. The generation of oxygen 
radicals in the proximity of DNA is well estabtisbed as a cause of strand scission 
(Ahmad et al, 1992; Bhat and Hadi, 1994; Rahman et al, 1989). It is generally 
recognized that such reactions with DNA are preceded by association of the ligand 
with DNA, followed by the production of oxygen radicals at that site (Pryor, 
1988). Degradation by 4-(9-acridinylamino) methanesu^hone-mranisidine (Wong 
et al, 1984), 1, 10-phenanthroline (Gutteridge and HalliweU, 1982), bleomycin 
(Ehrenfeld et al, 1987), adriamycin (Eliot et al, 1984; Haidle and McKinney, 
1985) as well as flavonoids (Ahmad et al, 1992; Rahman et al, 1989) is 
dependent upon metal ions by mechanisms involving ojQrgen-derived radicals. In 
these studies it was shown that a ternary conq)lex of the drug, DNA and Cu(II) is 
formed which generates oxygen radicals in situ via Cu(I). The results presented 
here show that resveratrol binds to Cu(II). Fukuhara and Mtyata (1998) have 
demonstrated that resveratrol is capable of binding to DNA and thus it would be 
reasonable to assume that a similar mechanism operates in the case of resveratrol-
Cu(II) mediated DNA cleavage. Further, the results with oxygen radical 
scavengers (Tables II and IV) indicate that thiourea, a quencher of hydrojqrl 
radical, is not very effective in inhibiting both the DNA cleavage as well as phage 
inactivation whereas catalase is the most effective quencher in both cases. This 
observation is in support of the findings of Fukuhara and Miyata (1998) yAist have 
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been detected in tissues such as kidney and liver, it is reasonable to assume that 
resveratrol is transported across cell membranes because of its lipophilic nature. It 
may be mentioned that it has been shown to bind to lipoproteins in plasma 
(Belguendouz et al., 1998). Further, resveratrol would be rendered more Iqjophilic 
as a con:5)lex with copper. It may be further mentioned that the apoptotic activity 
of the antioxidant gallic acid is abolished on modification of phenolic hydroxyl 
groups (required for copper chelation) (Inoue et al., 1994). This result correlates 
with a previous study in this laboratory where it was shown that such a 
nK>dificatk>n of gallic acid resulting in the formation of syringic acid also 
considerably reduces the DNA cleavage efSciency in tl^ presence of Cu(II) (Khan 
and Hadi, 1998). Pofyphenolic antioxidant curcumin has been shown to induce 
apoptosis in human leukemia cells and such apoptosis is prevented by superoxide 
dismutase or catalase (Kuo et al., 1996). Also, recentfy it has been reported that 
structural change in the antioxidant enzyme SOD, resulting from loss of zinc, is 
sufficient to induce apoptosis in cultured motor neurons (Estevez et al, 1999). It 
wouW thus appear that prooxidant action of polyphenolics rather than the 
antioxidant activity is responsible for the induction of apoptosis in these studies. 
Thus, one of the mechanisms could be that in tumor cells endogenous copper in 
serum or chromatin is relative^ easily mobilized by pofyphenolic conpotmds and 
similar ^)optosis inducing agents. Irrespective of the physiological significance of 
our results it is clear that resveratrol as a lead compound has implications for 
development of novel antitumor and cancer chemopreventive agents. 
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Protein fragmentation by resveratrol in the presence of Cu(II) 
Previous studies in this laboratory had shown that quercetin-Cu(II) system which 
cleaves DNA is also capable of protein fragmentation (Ahmed et ai, 1994). It was, 
therefore, of interest to examine whether resveratrol-Cu(II) system also possesses 
the same property. Figure 19 shows the fragmentation of BSA (2 mg/ml) by 
resveratrol in the presence of Cu(II). The method determines the formation of acid-
soluble amino groups by TNBS. The time dependent fragmentation of BSA in the 
presence of 100 jiM resveratrol and 50 nM Cu(II) (Figure 19A), as evidenced by 
an increase in the amount of acid-sohible amino acid groups, was found to be 
roughly linear up to 6 hours of incubation at 37^C. Increasing times of incubation, 
over 6 hours, did not result in any appreciable increase in the fragmentation of 
BSA and therefore, 6 hours of incubation was used for studying the dependency of 
BSA fragmentation reaction on resveratrol concentration and Cu(II) concentration. 
Increasing concentrations of resveratrol, at a fixed concentration (SO \iM) of 
Cu(II), resulted in an increase in the BSA fragmentation (Figure 19B). An increase 
in the BSA degradation was also observed with increasing concentrations of Cu(II) 
(Figure 19C) in the presence of 100 ^ M resveratrol. 
The degradation products of BSA, formed as a result of resveratrol-Cu(II) 
treatment, were analyzed on a 10% SDS-pofyacrylamide gel. The results shown in 
Figure 20 confirm the fiagmentation of BSA. Large aggregates of BSA are present 
in the commercial sample that migrate near the top of the gel (Hunt et ai, 1988*^ . 
These aggregates seem to get degraded on exposure to resveratrol and Cu(ll). At 
the 68 kDa BSA monomer position, there is an inpression of broadening of the 
stained band (smearing) after treatment with increasing concentrations of 
resveratrol (lanes d-g) in the presence of 50 ^M Cu(II). This is possibly due to a 
combination of overloading the staining system and monomer fi:agmentation to 
slightly smaller peptides. 200 fiM resveratrol alone (lane b) and 50 fiM Cu(II) 
alone (lane c) did not result in any BSA fiagmentation, as no change, with respect 
to the control sanple, was observed. The increasing concentrations of resveratrol 
resulted in an increase in the smearing thus verifying the feet that BSA is degraded 
by resveratrol in the presence of Cu(II). 
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Figure 19; Kinetics of protein fragmentation by resveratrol in the presence of 
Cu(II). 
BSA (2 mg/ml) was incubated with indicated concentrations of resveratrol and Cu(II) 
in a total reaction volume of 1.0 ml containing 10 mM potassium phosphate (pH 7.5) 
at 37°C. 
(A) Effect of increasing times of incubation in the presence of 100 pM resveratrol and 
50 nM Cu(II). (B) Effect of increasing concentrations of resveratrol in the presence of 
50 ^M Cu(II) after 6 hours of incubation. (C) Effect of increasing Cu(II) 
concentrations in the presence of 100 ^M resveratrol after 6 houis of incubation. Acid 
soluble amino groups were estimated as described in "Methods". All points represent 
triplicate samples and mean values have been plotted. 
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Figure 20: SDS/polyaciylaniide gel electrophoretic pattern of BSA after 
treatment with increasing concentrations of resveratroi in the 
presence of Cu(II). 
The reaction mixtures contained 20 ^g BSA, 10 mM potassium phosphate (pH 7.5), 
50 yM Cu(ll) and increasing concentrations of resveratroi in a total reaction volume of 
100 ^l. Incubation was carried out at 37°C for 6 hours. Lane a: BSA alone. Lane b: 
BSA + 200 i^M resveratroi. Lane c: BSA + Cu(II), Lanes d - g: [BSA + Cu(II)] + 25 
HM, 50 nM, 100 pM and 200 ^M resveratroi respectively. 
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Mechanism of BSA fragmentatioii by resveratrol 
To study the mechanism of fi:agmentation of BSA by resveratrol, bathocuproine 
and scavengers of reactive oxygen species were added to the reaction mixture prior 
to the addition of resveratrol (100 \iM) and Cu(II) (50 nM), Increasii^ 
concentrations of bathocuproine caused an inhibition of the resveratrol-Cu(II) 
mediated BSA fragmentation (Figure 21) confirming the essential role of Cu(I) in 
the reaction. The reaction was inhibited to an extent of 90% by 100 |xM 
bathocuproine. Scavengers of reactive oiiygen species were also found to inhibit 
the fragmentation of BSA (Table VI). Catalase caused the maximum inhibition 
while sodium azide and SOD also s^nificantly inhibited the fragmentation. 
Sodium benzoate was found to inhibit the fragmentation to some extent v^iereas 
thiourea caused only negligible inhitntion. These results suggest that BSA 
fragmentation by resveratrol in the presence of Cu(n) is mediated by the reduction 
of Cu(II) to Cu(I) and that Cu(I) is an essential intermediate in the reaction since 
sequestering of Cu(I) by bathocuproine almost complete^ inhibits the reactioiL 
Further, the redox recycling of copper ions results in the generation of reactive 
oJQ'gen species particular^ l^drogen peroxide, singlet o i^ygen and superoxide 
anion which serve as the proximal protein fragmenting species. A comparison of 
these results with those of preceding chapter suggests that the mechanism of 
protein fragmentation by resveratrol-Cu(II) is identical to DNA breakage reaction 
and is biologically relevant. 
Binding of resveratrol to BSA 
Figure 22 shows the changes in the fluorescence emission spectrum of BSA in the 
presence of increasing molar ratios of resveratrol When a solution of BSA was 
excited at its absorption maximum of 280 nm, a fluorescence emission spectrum 
with a maxima at 356 nm was observed (uppermost trace in the figure). Addition 
of increasing molar ratios of resveratrol to BSA resulted in a progressive 
quenching of the fluorescence emission. The results are suggestive of binding of 
resveratrol to BSA 
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Figure 21; Inhibition by bathocuproine of resveratrol-Cu(n) mediated 
fragmentation of BSA. 
2 mg/ml BSA was incubated with 100 ^M resveratrol, 50 jiM Cu(II) and increasing 
concentrations of bathocuproine at 37°C for 6 hours in a total volume of 1.0 ml 
containing 10 mM potassium phosphate (pH 7.5). Acid soluble amino groups were 
estimated as described in "Methods". All the points represent triplicate samples and 
mean values have been plotted. 
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Table VI; Percent inhibition of BSA fragmentation after treatment with 
resveratrol (100 ^M) and Cu(II) (50 jiM) in the presence of 
scavengers of ROS. 
Conditions 
Catalase(100ng/ml) 
Boiled catalase (100|ag/ml) 
Sodium Azide (50mM) 
Sodium Benzoate (50mM) 
Thiourea (50mM) 
SOD(100^g/ml) 
Inhibition (%) 
80.23 ±1.76 
5.21 ±0.23 
48.56 ±2.34 
20.43 ±0.19 
2.00 ± 0.05 
41.54 ±2.76 
SOD - Superoxide Dismutase 
All values are expressed as Mean ± SE for three different experiments. 
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Figure 22; Effect of increasing concentrations of resveratrol on the fluorescence 
emission spectra of BSA. 
BSA (in Tris-HCl, pH 7.5) was excited at 280 nm and the emission spectra were 
recorded between 300 and 400 nm. Traces, from top to bottom, are - BSA alone (1 
HM), BSA: resveratrol molar ratio 1:0.1, 1:0.2, 1:0.4, 1:0.6, 1:0.8, 1:1, 1:1.2, 1:5, 
1:7.5, 12, 1:2.5, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:10, 1:11, 1:12, 1:13, 1:14 and 1:15 
respectively. 
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The eJBFect of increasing molar ratios of BSA on fluorescence emission spectrum of 
resveratrol was also studied and the results are shown in Figure 23. When excited 
at its absorption maximum of 308 nm, resveratrol exhibited a fluorescence 
emission with a peak at arovmd 459 mn. Addition of BSA at molar ratios of 1, 10, 
20 and 30 resulted in a dose-dependent quenching of the fluorescence peak of 
resveratrol, thus showing binding of BSA to resveratrol. 
Binding of resveratrol to proteins with different tryptophan content 
L-tryptophan is one of the major chromophore among the naturally occurring 
amino acids and is re^)onsible for the absorbance shown by proteins at 280 nm. 
When excited at its absorption maximum of 280 nm, tryptophan was found to 
exhibit a fluorescence emission spectrum with peak at 375 nm. This peak was 
quenched by the increasing molar ratios of resveratrol (data not shown) in same 
pattern as that observed with BSA (Figure 22). An analysis of the quenching of 
tryptophan fluorescence by resveratrol revealed a linear relationshq) at lower 
concentrations of resveratrol However, as additional resveratrol was added, the 
concentration of unbound resveratrol increased in a manner predicted by the mass-
action equation and the afSnity constant. The effect of about 40 increasing molar 
ratios of resveratrol on the tryptophan fluorescence was studied. The fractional 
quench was calculated as described in "Methods". This data was utilized to 
construct scatchard plots for determining the binding capacity and aJOGnity of 
resveratrol for tryptophan. The scatchard plot for the binding of resveratrol to 
tryptophan is shown in Figure 24 (a). An analysis of this plot revealed that 2.19 
moles of resveratrol are able to bind to one mole of tryptophan and the association 
constant of such binding is of 4.7 x lO' liter/mol (Table VII). 
Similar fluorescence quenching e?q)eriments were performed with 3 different 
proteins with varying number of tryptophan residues. Chymotrypsin has 1 
tryptophan, BSA has 2 tryptophan residues v^ liile lysozyme has 6 tryptophan 
residues. Fhiorescence quenching titration of these proteins was performed by 
adding increasing molar ratios of resveratrol in exactly the same way as done with 
tryptophan and the subsequent scatchard plots are shown in Figure 24. The analysis 
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Figure 23; Effect of increasing concentrations of BSA on the fluorescence 
emission spectra of resveratroL 
Resveratrol (in Tris-HCl, pH 7.5) was excited at its Xmax (absorption) of 308 nm and 
the emission spectra were recorded between 360 and 580 nm. 
Trace 1 : resveratrol alone (5 yM) 
Trace 2 : resveratrol: BSA molar ratio 1:1 
Trace 3 : resveratrol: B SA molar ratio 1:10 
Trace 4 : resveratrol: BSA molar ratio 1:20 
Trace 5 : resveratrol: BSA molar ratio 1:30 
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Figure 24; Scatchard plots for binding of resveratrol to proteins with different L-
tiyptoplian content 
Fluorescence titration of proteins was performed by adding increasing amounts of 
resveratrol to L-ttyptophan/protein solutions. This data was utilized to generate 
scatchard plots for binding of resveratrol to (a) L-tryptophan, (b) Chv-motrypsin, 
(c) BSA and (d) Lysozyme. A detailed methodology is given in "Methods". 
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Table VII; Binding constants of resveratrol for proteins with vaiying number 
of L-tryptophan residues. 
Amino 
Acid/Protein 
Tryptophan 
Chymotrypsin 
BSA 
Lysozyme 
Number of 
L-tryptophan 
residues 
1 
1 
2 
6 
Association 
constant (K«) 
(liter mol'^ ) 
4.7 X10' 
5.0x10' 
1.4x10' 
5.7 X 10' 
Moles of 
resveratrol/mole 
of protein 
2.19 
5.58 
2.89 
2.82 
All the values were calculated from the scatchard plots given in Figure 24. 
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of scatchard plots as tabulated in Table VII revealed that 5.58 moles of resveratrol 
bind to one mole of chymotrypsin, 2.89 moles of resveratrol bind to one mole of 
BSA and 2.82 moles of resveratrol bind to one mole of fysozyme. The number of 
moles of resveratrol bound per mole of BSA and fysozyme was quite similar 
although there is great difference in the number of tryptophan residues. Lysozyme 
contains three times the tryptophan residues as BSA. This would suggest that the 
tryptophan residues in fyso:grme are buried inside and are possibfy not available 
for binding to resveratrol Chymotrypsin contains only one tryptophan residue and 
still the number of moles of resveratrol bound to one mole of it was quite high. 
This may presumabty be due to the binding of resveratrol to some other amino 
acids or may be a result of some non-specific binding which is not quite easy to 
characterize. 
An analysis of the association constants of resveratrol for these proteins (Table 
VII) also showed a variation which does iK)t appear to be related to their 
tryptophan content. The interesting result is that the association constant for 
tryptophan alone and the single tryptophan containing chymotrypsin was quite 
similar [4.7 and 5.0 (x lO' liter/mol) respectively]. However, even the association 
constant for 6 tryptophan residues-containing lysozyme was not very high (5.7 x 
lO' liter/mol) whereas the association constant for BSA was the lowest (1.4 x 10^  
liter/mol). Taken together these results seem to suggest a coni^lex mode of binding 
of resveratrol to proteins v^ch might involve, in addition to tryptophan residues, 
some non specific interactions. 
To further substantiate the above findings, effect of increasing molar ratios of 
resveratrol on a few more proteins was compared with the proteins described 
above. The results are given in Table VIII. The quenching effect of resveratrol 
molar concentration (5 times) on the fluorescence emission of tryptophan alone 
(58.3%) was quite similar to that on single tryptophan-containing RNase Tl 
(60.1%) whereas it was significant^ different (78.0%) in the case of other single 
tryptophan-containing protein-chymotrypsin. However, the quenching effect of 
resveratrol at molar ratio of 2 was quite similar in case of RNase Tl and 
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Table VIII; Effect of resveratrol on fluorescence of different proteins with 
varying number of L-tryptophan residues. 
Amino 
acid/Protein 
Tryptophan 
Chymotrypsin 
RNaseTl 
BSA 
Lysozyme 
Catalase 
Pepsin 
Number of 
Tryptophan 
1 
1 
1 
2 
6 
6 
6 
Ratio of 1 
resveratrol/protein 
0 
1 
2 
5 
0 
1 
2 
5 
0 
1 
2 
5 
0 
1 
2 
5 
0 
1 
2 
5 
0 
1 
2 
5 
0 
1 
2 
5 
Amax 
375 
368 
325 
356 
358 
356 
361 
% 
fluorescence 
100.0 
80.0 
73.3 
58.3 
100.0 
94.3 
83.0 
78.0 
100.0 
98.3 
83.4 
60.1 
100.0 
74.8 
56.8 
36.1 
100.0 
74.8 
73.7 
52.8 
100.0 
93.2 
88.4 
61.9 
100.0 
89.1 
82.6 
49.3 
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chymotiypsin (83.4 and 83.0% respectively) and was significantly different firom 
that observed with tryptophan alone (73.3%). The proteins containing six 
tryptophan residues- lysozyme, catalase and pepsin also showed a different pattern 
of quenching on addition of increasing molar ratios of resveratroL The quenching 
in case of catalase was less as coinpared to tryptophan alone. All this data, taken 
together, suggests a complex mode of binding of resveratrol to proteins probably 
involving some non-specific interactions and confirms the results of Table VII. An 
intoesting observation was the maximal rate of quenching observed with BSA. 
This could possibfy be because BSA has a relative^ less conqilicated tertiary 
structure and the tryptophan residues are comparative^ easily available for 
binding. 
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Oxygen radicals are believed to be generated by a number of physiological 
processes and such radicals have been proposed as the agents responsible for 
destruction of model peptides via labile iminopeptides (Holian and Garrison, 
1969). The sensitivity of proteins to oj^gen radical attack is well established. Such 
radicals can be formed from y-irradiation (Wolff and Dean, 1986) and by metal 
ions and H2C)2 (Ahmad et al., 1992), Cu(II) and ascorbate (Marx and Chevion, 
1986) and glucose in the presence of oxygen and Cu(II). The last reaction is 
inqMrtant since it {^pears to contribute, by the Amadori rearrangement, to the 
glycation of proteins during diabetes and seeing (Hunt et al., 1988*). 
Fragmentation of BSA by radiofyticalfy generated hydro^ Q^ l radicals has been 
reported (Schuessler and Schilling, 1984). Additional^, several radical species 
have been shown to produce conformational changes in the proteins resulting in an 
enhanced susceptibility to enzymatic hydro^is (Wolff and Dean, 1986). Radicals 
generated within whole cartilage discs have been shown to degrade proteoglycan, 
appaientfy by selective fragmentation of the core protein (Dean et al., 1984) and 
there is considerable data to indicate that radicals can inactivate proteins by 
modification of amino acid residues (Wilson, 1983). 
In this ch^ter, I have studied the interaction of resveratrol with proteins. The 
results clearly indicate the fragmentation of BSA by resveratrol in the presence of 
Cu(II). Cu(I), which is formed as a result of reduction of Cu(II) by resveratrol 
(Figure 6, Chapter 1), is shown to be an essential intermediate in this fragmentation 
reaction (F^iJre 21), This finding, together with that involving scavengers of 
oxygen fiw radicals (Table VI), suggests that the fragmentation of BSA by 
resveratrol-Cu(II) possibly involves a pathway similar to that responsible for the 
DNA cleavage activity. The other results, presented in this chapter, show binding 
of resveratrol to BSA and other proteins, Resveratrol has been shown to bind to L-
tryptophan and various proteins with different number of tryptophan residues, as 
suggested by fluorescence quenching e:q)eriments. 
The association constant of resveratrol for various proteins is of the order of lO' 
liter/mol (Table VII). Many drugs (synthetic organic anions) have an association 
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constant of approximately 10'* liter/mol for physiological proteins (Meyer and 
Guttman, 1968) while the same of antibodies for their antigens is of the order of 
lO' liter/mol (Davis et al, 1967). This would suggest that binding of resveratrol to 
proteins might not be stereospecific, as in the case of antibodies, but it is still 
stronger than that observed for non-specific, electrostatic interactions. This, in part, 
is accounted by binding of resveratrol to L-tryptophaiL A detailed study, involving 
proteins with varying tryptophan content, was carried out to investigate site-
specific binding of resveratrol to proteins. The results, however, are not very 
suggestive of tryptophan-specific binding of resveratrol to proteins. Instead it 
spears that resveratrol, in addition to tryptophan, may bind to other amino acids 
and also, non-specifically to the proteins. Further, the inconclusive data of proteins 
with varying tryptophan content could be attributed to the feet that the tryptophan 
residues in many proteins are buried inside the tertiary structure and are not readify 
available for interaction with resveratrol 
As mentioned earlier, resveratrol can bind to Cu(II) and to proteins. Thus, a 
protein-resveratrol-Cu(II) conplex can be enviss^ed, similar to DNA-resveratrol-
Cu(II) complex. Such a con^lex probabfy accounts for the protein fragmentation 
ability of resveratrol via the generation of oxygen fi%e radicals >^ch are known to 
cause damage in close vicinity of their production site. It is worth mentioning that 
proteins, damaged by free radicals, have been shown to contain s^nificant 
amounts of protein peroxides and a protein bound reducing moiety >^ch can 
reduce copper ions (Gieseg et a/., 1993). Such a radical damage might play a 
significant role in the propagation of pathological radical damage; firstly, by being 
stable enough to difiuse from the site of the initial radical generating event and 
thus transmitting the radical damage to new locations and secondfy, by being able 
to promote fiirther radical generating reactions by replenishing the levels of 
reduced metals available to carry out Haber-Weiss type reactions. In conclusion, 
the data presented here confirms that the free radicals generated by resveratrol and 
Cu(II) do cause fragmentation of BSA. The spectrofluorimetric evidence for the 
binding of resveratrol to proteins relates to some non-specific binding and, in part, 
to changes in fluorescence of tryptophan residues. Future e:q)eriments on other 
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proteins with different structural features, in particular the number and 
environments of tryptophan and other amino acids containing conjugated side 
chains (phenylalanine, tyrosine and histidine) will establish the generality of the 
process. The positions of fragmentation have not been established in this work, but 
it seems that the primary sites may be histidine and proline residues, as these are 
the primary targets for free radicals generated by Cu(II)/H202 and also by y-
radiolysis (Dean et al, 1989). 
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Formation of a complex involvmg calf thymus DNA and resveratrol 
Figure 25 shows the effect of addition of increasing base pair nK)lar ratios of calf 
thymus DNA on the fluorescence emission of resveratroL Such an addition 
resulted in a dose-dependent quenching of the fluorescence. There was, however, 
no shift in the X^ ax emission suggestii^ a single mode of binding of DNA to 
resveratroL The addition of native and denatured forms of calf thymus DNA on 
fluorescence emission of resveratrol was also studied and the results are shown in 
Figure 26. The native as well as denatured form of DNA had a quenching effect on 
the fluorescence emission of resvCTatroL However, the quenching observed with 
denatured DNA was slightly more than that observed with native DNA The 
control, native DNA alone, when excited at the same wavelei^;th (308 nm) did not 
interfere with the emission spectrum of the resveratrol alone/resveratrol + DNA 
thus confirming the binding results. These results demonstrate the ability of 
resveratrol to bind to both double-stranded and single-stranded DNA 
Binding of copper ions to resveratrol 
Binding of copper ions to resveratrol was studied by the effect of increasing Cu(II) 
molar ratios on the fluorescence emission spectrum of resveratroL The results 
shown in Figure 27 clearly indicate the binding as addition of Cu(II) causes 
quenching of the resveratrol fluorescence. It is worth mentioning that the addition 
of Cu(II) at molar ratios as low as 0.1 and 0.5 caused substantial quenching of the 
fluorescence. This indicates a strong binding of copper ions to resveratrol and 
supports the results of absorption studies shown in Figure 10 where formation of a 
resveratrol-Cu(II) complex is demonstrated. 
Formation of a ternary complex of resveratrol-Cu(II)-DNA 
Since resveratrol binds to DNA (Figure 25) and copper ions (Figures 10 and 27), it 
was of interest to determine v i^iether a ternary complex involving resveratroL 
Cu(II) and DNA is formed. It is worth mentioning that earlier studies in this 
laboratory have demonstrated the formation of a ternary con:q)lex in the flavonoids-
Cu(II)-DNA cleavage system (Rahman et al, 1989, 1990). Fhiorescence studies 
shown in Figure 28 indicate the formation of such a con^lex. As seen in figure, 
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Figure 25; Effect of increasing native DNA base pairs on the fluorescence 
emission spectra of resveratroL 
Resveratrol (in Tris-HCl, pH 7.5) was excited at its Xmax (absoiption) of 308 nm and 
the emission spectra were recorded between 350 and 600 nm. 
Trace 1 : resveratrol alone (10 ^M) 
Trace 2 : resveratrol: DNA base pair molar ratio 1:10 
Trace 3 : resveratrol: DNA base pair molar ratio 1:20 
Trace 4 : resveratrol: DNA base pair molar ratio 1 -30 
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Figure 26; Effect of native and denatured DNA on the fluorescence emission 
spectra of resveratroL 
Resveratrol (in Tris-HCl, pH 7.5) was excited at its Xmax (absorption) of 308 nm and 
the emission spectra were recorded between 300 and 600 nm. 
Trace 1 : resveratrol alone (10 ^ M) 
Trace 2 : resveratrol: native DNA molar ratio 1 '25 
Trace 3 : resveratrol: denatured DNA molar ratio 1:25 
Trace 4 : native DNA (250 \iM) alone 
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Figure 27; Effect of increasing concentrations of Cu(II) on the fluorescence 
emission spectra of resveratroL 
Resveratrol (in Tris-HCl, pH 7.5) was excited at its Xmax (absorption) of 308 nm and 
the emission spectra were recorded between 300 and 600 nm. 
Trace 1 : resveratrol alone (10 pM) 
Trace 2 : resveratrol: Cu(II) molar ratio 1:0.1 
Trace 3 : resveratrol: Cu(II) molar ratio 1 K).5 
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Figure 28; Detection of a ternary complex involving resveratrol, DNA and Cu(II). 
Resveratrol (in Tris-HCl, pH 7.5) was excited at its Xmax (absorption) of 308 nm and 
the emission spectra were recorded between 370 and 600 nm. 
Trace 1 : resveratrol alone (10 (iM) 
Trace 2 : resveratrol: DNA molar ratio 1:20 
Trace 3 : resveratrol: Cu(II) molar ratio 1:0.1 
Trace 4 : resveratrol: DNA: Cu(II) molar ratios 1:20:0.1 
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RESULTS-m 
addition of Cu(n) and DNA resulted in a quenching of the fluorescence emission 
peak of the resveratrol and the effect was considerably greater from that observed 
on the addition of same concentrations of Cu(II) alone or DNA alone to 
resveratrol. 
Scoring of mutations in lacZ gene caused by resveratrol-Cu(II) 
It is well established that the common types of activation mechanisms of 
oncogenes inchide point mutations, translocations and aiiq)lifications, whereas 
point mutations and deletions ^pear to be the mechanisms for inactivation of 
tumor suppressor genes (Bishop, 1991). In the first chapter, I have demonstrated 
the ability of resveratrol to induce strand nicks in plasmid DNA (Figure 4). The 
mutagenicity of resveratrol in plasmid DNA was assayed by treating plasmid 
Bhiescript SK(+) DNA with increasing concentrations of resveratrol in the 
presence of 50 nM Cu(II) for 2 hours at 37*C and measuring the loss in 
transformation efficiency of the plasmid in E. coli DH5a cells (Figure 29A). The 
fold increase in mutant colonies was also studied and the results are shown in 
Figure 293. The mutants were identified on the basis of >\1iite colonies >\1iich they 
formed due to mutations in the non-essential lacZ gene. It is well known that 
vectors such as plasmid Bluescrq)t SK(+) containing a portion of the lacZ gene 
provide a-con^lementation when plated on cells containing kcl ""Z M15 cassette 
on the tetracycline resistant F' episome which makes them suitable for blue: white 
screening on plates supplemented with X-gal and IPTG (Short et al, 1988). Figure 
29A shows that the loss of transformation capacity is linearly related to the 
resveratrol concentratioa Conversely, the generation of mutants lacking a-
complementation showed increased fi«quency with increasing resveratrol 
concentrations (Figure 29B). 
Structural alterations in the plasmids isolated from mutants 
Plasmid Bluescript SK(+) was treated with increasing concentrations of resveratrol 
in the presence of 50 ^M Cu(II) and plasmid DNA was isolated from the 
confirmed mutants. Electrophoresis was done on 1% s^arose gels along with 
control pBluescript DNA. Figure 30 shows that all the mutants were approximately 
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Figure 29; Effect of resveratrol on transformation capacity of plasmid. 
A 100 ng plasmid sample in a total reaction volume of 50 ^l was treated with 
increasing concentrations of resveratrol in the presence of 50 \il Cu(II) at 37°C for 2 
hours. See "Methods" for details. 
(A) Effect of resveratrol on percent transformation capacity of plasmid Bluescript 
SK(+) in competent E. coli DH5a cells. (B) Effect of resveratrol on the number of 
mutant (white) colonies. 
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Figure 30; Size determination of mutant plasmids generated by resveratrol-
Cu(n). 
Treatment of plasmid Bluescript SK(+) DNA with resveratrol-Cu(II) and isolation of 
mutants is described in "Methods". Plasmid DNA was isolated from mutants by 
mini/maxi preparations and run on 1% agarose gels. Cu(II) concentration was 50 ^M 
in all the cases. 
(A) Lane a: untreated plasmid. Lane b: plasmid + Cu(II), Lane c: plasmid + 10 pM 
resveratrol. Lane d: plasmid + 10 [xM resveratrol + Cu(ll), Lane e: plasmid + 20 pM 
resveratrol. Lane f: plasmid + 20 pM resveratrol + Cu(II), Lane g: plasmid + 50 pM 
resveratrol. Lane h: plasmid + 50 pM resveratrol + Cu(II). 
(B) Lane a: untreated plasmid. Lane b: plasmid + 100 pM resveratrol. Lane c: plasmid 
+ 100 jiM resveratrol + Cu(II), Lane d: plasmid + 150 pM resveratrol. Lane e: plasmid 
+ 150 pM resveratrol + Cu(II), Lane f: plasmid + 200 pM resveratrol. Lane g: plasmid 
+ 200 pM resveratrol + Cu(II). 
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of the same size. These results suggest that the mutagenicity of resveratrol-Cu(II) 
system on plasmid DNA possibly involves only point mutations and there is no 
major excision of DNA segment such as that resulting in decreased size of the 
plasmid which may be detected by agarose gel electrophoresis. 
Mutation analysis of resveratrol-Cu(II) induced DNA damage 
Mutants unable to carry out a-complementation (white colonies), generated 
spontaneously or due to the resveratrol treatment in the presence of Cu(II), were 
picked from the nutrient agar plates, grown and the plasmid DNA was isolated 
from their overnight culture. The plasmid DNA was sequenced as described in 
"Methods". Figure 31 illustrates the map of plasmid Bluescript SK(+). 
PvuII 532 
KpnI657 
M13 primer 
i 
816 
Reverse primer 
Figure 31; Map of plasmid Bluescript SK(+) 
A 327-base sequence [bases 490-816 in plasmid Bluescript SK(+)] of lacZ gene 
was sequenced and the sequence obtained for each mutant was compared with that 
of the control. As a representative, the distribution of mutations in both untreated 
(spontaneous) and resveratrol-treated plasmids within the 129 base sequence from 
PvuII restriction site to Kpnl restriction site in lacZ gene is shown in Figure 32. 
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Figure 32; Mutation spectra of resveratrol-Cu(II)-induced DNA damage in 
plasmid. 
The 129 base DNA sequence fix)m PvuII restriction site to Kpnl restriction site in lacZ 
gene is shown. The sequence shown in the bottom represents the anti-sense strand of 
the wild type lacZ gene of the plasmid. Each symbol above the sequence represents a 
single base change in the corresponding mutant 
* - single base deletion 
t - single base T insertion 
X - single base C insertion 
i-GCGCGC 
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RESULTS-m 
The sequence of mutants generated by treatment of Cu(II) (50 pM) alone or by 
resveratrol alone at all the concentrations tested is also given. An analysis of the 
mutations revealed that a majority of mutations were deletions and substitutions. 
The frequency of mutations was greater in case of resveratrol-Cu(II) treated 
plasmids as compared to spontaneous mutants and a dose-dependency of the 
frequency of mutants on the concentration of resveratrol was observed. At higher 
concentrations of resveratrol insertion mutations were also observed. The most 
interestii^ observation was that in two of the three mutants, generated by treatment 
with 200 \iM resveratrol and 50 ^M Cu(II), a three base sequence - ATT (position 
622-624 in plasmid) was replaced by a six base sequence - GCGCGC. Exactly 
similar sequence was also observed in a mutant generated by the treatment of 200 
^M alone. An electropherogram (generated by the automated DNA sequencer) 
showing this mutation is given in Figure 33. The electropherogram clearly shows 
the aforesaid change (ATT->GCGCGC) in the plasmid sequence. It £^pears that 
resveratrol is able to bind to some specific sequence in the vicinity of this sequence 
and may thus cause this mutation. However, this can onty be speculated at the 
moment. In frict, a few other observations reduce this event to a chance happening. 
Firstly, no such mutation is observed at the lower concentrations of resveratrol, and 
secondly, the sequence ATT appears a total of 6 times in the lacZ gene and in a 
few cases the flanking sequence is also quite similar but still at none of these sites 
such a major change was observed. In spite of the lack of conclusive evidence 
regarding the sequence specificity of binding and mutagenicity of resveratrol, the 
results presented here underline the potential of resveratrol with regards to 
mutagenicity in plasmid DNA and suggest induction of sequence specific 
mutations at h ^ e r concentrations. 
A comparison of the different types of mutations caused by resveratrol-Cu(II) in 
the 327 base sequence of lacZ gene of plasmid bluescript is given in Table IX. The 
study revealed that although substitutions were predominant in the spontaneous 
mutants, the treatment with resveratrol and/or Cu(II) resulted in an increase in the 
percentage of deletions mutations. At almost all the concentrations of resveratrol 
teste4 the percentage of deletion mutations was the highest. At lower 
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Figure 33; Eiectropherogram showing tiie mutation at position 622-624 in 
plasmid Bluescript SK(+) after treatment with resveratrol-Cu(II). 
Plasmid Bluescript SK(+) was treated with 200 JJM resveratrol in the presence or 
absence of 50 pM Cu(II) and the resulting mutant was isolated and sequenced as 
described in "Methods". The eiectropherogram shown here was generated by 
automated DNA sequencer. Towards the bottom of the figure, an alignment of the 
sequence of mutant (lower sequence) with control plasmid (upper sequence) is given. 
Middle sequence is the consensus sequence. The sequence in eiectropherogram is that 
of the sense strand (5' to 3') A\4ule the aligning sequences (lower panel) are those of 
the anti-sense strand, reading 5' to 3'. 
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Table IX: Percentage of different types of mutations (deletions, substitutions 
and insertions) in plasmid Bluescript on treatment with 
resveratrol(R) and Cu(II)(C). 
Control 
C (50^M) 
RlOuM 
RlO^M+CSOuM 
R20^M 
R20^M+C50nM 
R50nM 
R50HM-K:50HM 
RlOOuM 
RlOOnM+CSOuM 
RlSOuM 
R150HM-K:50HM 
R200nM 
R200^M+C50^M 
Deletions 
(%) 
27.6 
40.9 
71.4 
78.1 
66.7 
71.9 
66.7 
65.7 
50.0 
63.0 
42.9 
46.7 
38.5 
44.0 
Substitutions 
(%) 
72.4 
59.1 
28.6 
18.8 
33.3 
25.0 
33.3 
25.7 
50.0 
21.8 
57.1 
31.1 
38.5 
32.0 
Insertions 
(%) 
-
-
-
3.1 
-
3.1 
-
8.6 
-
15.2 
-
22.2 
23.0 
24.0 
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concentrations of resveratrol, insertions were almost absent but their share was 
found to increase at higher concentrations and at the resveratrol concentrations of 
150 and 200 i^M, about a quarter of the mutations were insertions. A fiirther 
analysis of the data was done and the percentage of three different types of 
mutations at the four bases was calculated (Table X). An interesting finding was 
that guanine was the most susceptible base with respect to deletions and in the case 
of treatment of plasmid with resveratrol alone, almost all the deletions were limited 
to guanine bases, particularly at the higher concentrations. The substitutions were 
quite ^rly distributed and thymine base seemed to be marginally more susceptible 
to this type of mutation. As mentioned earlier, insertions were found to be rare 
events at lower concentrations (10, 20 and 50 \iM) of resveratrol but were 
significant^ present at the higher concentrations (100, 150 and 200 ^M). Cytosine 
seemed to be more wdnerable to these types of mutations. 
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Table X: Differential distribution of mutations- deletions, substitutions and 
insertions in plasmid pBS after resveratrol(R)-Cu(n)(C) treatment. 
G C 1 A T 
Deletions (*/•) 
Qmtrol 
C(50nM) 
R10^M 
RlOnM+CSOpM 
RlOpM 
R20HM+C50MM 
R50(iM 
R50fiM+C50nM 
RlOOfiM 
R100(iM4CS0(iM 
RlSOpM 
R150nM+C50pM 
R200^M 
R200nM+C50tiM 
37.5 
44.5 
100.0 
68.0 
75.0 
60.9 
75.0 
56.5 
100.0 
58.7 
100.0 
52.4 
80.0 
54.6 
25.0 
22.2 
-
16.0 
-
21.7 
-
17.4 
-
172 
-
14.3 
20.0 
18.2 
12.5 
22.2 
-
8.0 
25.0 
8.7 
25.0 
8.7 
-
6.9 
-
28.6 
-
13.6 
25.0 
11.1 
-
8.0 
-
8.7 
-
17.4 
-
17.2 
-
4.7 
-
13.6 
SaiMtttntioiis (%) 
Coatrol 
C(50nM) 
RlOpM 
RIOMM+CSOMM 
R20(xM 
RZOnM+CSOjiM 
RSOpM 
R50nM+C50nM 
RIOO^M 
R100nM+C50nM 
R150nM 
R150nM+C50nM 
R200nM 
R200^M4C50nM 
19.0 
30.8 
-
16.7 
-
25.0 
100.0 
22.2 
33.3 
40.0 
25.0 
14.3 
-
25.0 
28.6 
7.6 
-
33.3 
50.0 
25.0 
-
22.2 
-
10.0 
50.0 
-
40.0 
6.3 
23.8 
30.8 
50.0 
33.3 
-
12.5 
-
33.4 
-
20.0 
-
21.4 
20.0 
25.0 
28.6 
30.8 
50.0 
16.7 
50.0 
37.5 
-
22.2 
66.7 
30.0 
25.0 
64.3 
40.0 
43.7 
Insertions (%) 
Control 
C(50^M) 
RlOuM 
RlOnM+CSOjiM 
R20nM 
R20nM+C50nM 
RSO|xM 
R50nM+C50nM 
RIOOMM 
RlOOnM+CSOuM 
RlSOuM 
R150^M+C50^M 
R200nM 
R200HM-K:50HM 
-
-
-
-
-
-
-
-
-
14.3 
-
20.0 
33.3 
16.7 
-
-
-
-
-
-
-
66.7 
-
57.1 
-
50.0 
66.7 
66.7 
-
-
-
-
-
-
-
-
-
14.3 
-
20.0 
-
8.3 
-
-
-
100.0 
-
100.0 
-
33.3 
-
14.3 
. 
10.0 
-
8.3 
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Oxidative DNA damage is caused by ROS. Several base oxidation products have 
been characterized and one of the major ones is that resulting from C-8 
hydroxylation of guanine residues generating 8-hydroxy-2'-deojqrguanosine 
(Oxo'dG). The ratio of Oxo*dG to the undamaged nucleoside deoxyguanosine 
(dG) has been widefy used as a reliable marker for oxidative DNA damage in vivo 
and in vitro. Oxo'dG has been particularly implicated in carcinogenesis (Floyd, 
1990), since it induces misreading during DNA synthesis in vitro and leads to G > 
T transversion mutagenesis (Cheng et al., 1992; Kuchino et al., 1987). 
In chapter 1, I have shown degradation of plasmid DNA on treatment with 
resveratrol and Cu(II). Earlier studies have revealed that repair of damaged 
plasmid DNA takes place on propagation in the host E. coli (Khan and Hadi, 
1993). In the studies reported in this ch£q)ter, I have investigated the miit^^enicity 
of resveratrol on plasmid DNA. The mutations have been characterized by using 
the lacZ gene for p-galactosidase as a target. The results indicate that resveratrol, 
in the presence of Cu(II), induces point mutations, particularly the deletions. 
Substitution type of mutations are the more abundant type in spontaneous 
mutations but are also significantly present in mutants generated by resveratrol-
Cu(II) treatment. Insertions are observed only at high concentrations of resveratrol 
and there is also a dose-dependent increase in the frequency of mutations. It has 
been suggested that a ternary con^lex of the drug, DNA and Cu(II) is formed 
which generates oxygen radicals in situ via Cu(I) (Rahman et al., 1989, 1990). As 
shown in the present study, resveratrol is capable of binding copper ions (Figures 
10 and 27) and DNA (Figure 25) and forms a DNA-resveratrol-Cu(II) ternary 
coir^lex (Figxire 28). It would thus be reasonable to assume that such a mechanism 
operates in resveratrol-Cu(II) mediated mutagenesis. 
The concentration of copper ion in blood is about 16jiM (Sagripanti et al., 1991). 
Further, diet-derived copper enters the liver preferentially in the monovalent Cu(I) 
form (Dijkstra et al., 1997). Interesting^, this ion has been found at higher 
concentrations in breast tumors as con^ared with the normal breast tissue (Linder, 
1991; Margalioth et al., 1983). The data presented here (Table X) clearly indicates 
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that guanine is most susceptible to deletions on treatment with resveratrol-Cu(II). 
Further, treatment with resveratrol alone, particularly at high concentrations, 
resuhs in deletion of only guanine residues. This is an interesting finding and can 
possibly be accounted for by the feet that at the cellular level, approximately 20% 
of copper is located in the nucleus (Agarwal et ai, 1989), associated more 
specifically with DNA bases, particularly guanine (Bryan et al., 1981; Kagawa et 
aL, 1991; Prutz et al., 1990; Wacker and Vallee, 1959). Thus, it seems plausible 
that guanine-associated Cu(II) is mobilized by resveratrol leading to its redox 
recycling and concomitant production of ROS, resulting finally in mutation at this 
site. This possibility is fiirther supported by the observation that addition of Cu(II) 
in the reaction mixture resulted in deletion mutations of other bases as well. 
Indeed, Li and Trusli (1994) have proposed that the DNA-associated copper in 
cells may have the potential to activate phenolic compounds via a copper-redox 
reaction, producing reactive oxygen and electrophilic intermediates leading to a 
spectra of lesions in DNA, including oxidative DNA base modifications, DNA 
strand breaks and DNA adducts of phenolic intermediates. The present studies do 
not establish sequence-specific bindii^ of resveratrol to DNA. However, as 
pointed out in the first chapter, the mechanism of action of resveratrol is similar to 
certain anticancer drugs and thus there exists a possibility that resveratrol may 
have a preference of binding to certain mono-, di- or trinucleotide sequences as 
seen in the case of an anticancer drug- diianomycin (5'-A/T CG and S'-A/T GC) 
(Chaires era/., 1990). 
In recent years, a number of reports have appeared where it has been shown that 
programmed cell death or apoptosis (including intemucleosomal DNA 
fitigmentation) can be induced by plant derived polyphenolic compounds through 
mechanisms that may be different fi-om the physiological such as those involving 
the fes receptor. As mentioned in 'Introduction' resveratrol is capable of inducing 
apoptotic cell death and DNA fi-agmentation in various cancer cell Unes. There is 
evidence to suggest that the antioxidant properties of polyphenolics may not 
entirely account for their preventive effects j^ainst cancer and apoptosis induction. 
For example, it has been recently shown that the programmed ceU death induced 
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by resveratrol in THP-1 human monocytic leukemia cells is independent of Fas 
signaling pathway (Tsan et al, 2000), suggesting the existence of pathways 
different than the classical A number of reports indicate that serum (Ebadi and 
Swanson, 1988) and tissue (Yoshida et al, 1993) copper levels are significantly 
increased in various malignancies. We have, therefore, recently proposed a 
mechanism for the cytotoxic action of plant-derived polyphenolic compounds 
against cancer cells involving mobilization of endogenous copper and the 
consequent prooxidant action (Hadi et al., 2000). It is thus possible that resveratrol 
induced apoptotic DNA fragmentation can be e?q)lained by the ability to mobilize 
endogenous /elevated copper levels in cancer cells. 
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Abstract 
Resveratrol (3,4',5-trihydroxy stilbene) is a phytoalexin and a polyphenolic compound present in human dietary material 
such as peanuts, mulberries, grapes and red wine. It is widely considered to possess cardiovascular protective properties and has 
also been shown to be chcmoprevcniive against various stages of chemically induced carcinogenesis. It has recently been shown 
that resveratrol induces strand breakage in DNA in the presence of copper ions. In this paper, we have shown that resveratrol 
catalyzes the reduction of Cu(n) to Cu(I), which is accompanied by the formation of 'oxidized product(s)' of resveratrol, which 
in turn also appear to catalyze the reduction of Cu(II). Strand scission by the rcsveratrol-Cu(II) system was found to be 
biologically active as assayed by bacteriophage inactivation. The results are discussed in relation to the putative chemopre-
ventive mechanism of resveratrol. C 2000 Elsevier Science Ireland Ltd. All rights reserved. 
Keywords: Resveratrol: DNA damage: Cu(II) reduction; Reactive oxygen species; Phage inactivation 
1. Introduction 
Resveratrol (3.4'.5-trihydroxy stilbene) belongs to 
a class of compounds known as phytoalexins and has 
been isolated from several spermatophytes of which 
grapevine, peanuts and pines are the prime represen-
tatives. Studies on resveratrol have gained momentum 
in the last few years because of the phenomenon of 
'French paradox", which refers to the paradoxical 
finding that the incidence of coronary heart disease 
in the population of Southern France is relatively 
low inspiie of high intake of saturated fats in the 
diet. This phenomenon has been correlated with a 
higher intake of red wine in this region with resvera-
• Corresponding author. Te!.: +91-571-400-741; fax: +91-571-
400-466. 
E-mail address: smhadi@del6.vsnl.net.in (S..M. Hadi) 
trol being identified as the major constituent respon-
sible for this effect. 
Resveratrol has been reported to have a variety of 
anti-inflammatory [1], anti-platelet [2], anti-muta-
senic [3] effects and has been shown to be an agonist 
for the estrogen receptor [4], a property which is rele-
\ ant to its reported cardiovascular protective proper-
ties. It has been found to confer resistance to plants 
against fungal infections [5] and inhibit DNA poly-
merase [6] and ribonucleotide reductase [7]. Frankel 
et al. [8] demonstrated the inhibition of LDL oxida-
tion by resveratrol and Belguendouz et al. [9] have 
attributed this activity of resveratrol to its ability to 
chelate copper ions. Resveratrol has also been impli-
cated as a cancer chemopreventive agent capable of 
inhibiting all the three stages of chemical carcinogen-
esis namely tumor initiation, promotion and progres-
sion [1]. In agreement with the findings that cancer 
0304-3835/00/S - see front matter © 2000 Elsevier Science Ireland Ltd. .W) rights reserved. 
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chemopreventive agents can induce apoptosis [ 10,11 ]. 
resveratrol has been shown to induce apoptosis in 
human tumor cells [12,13]. 
Earlier studies in our laboratory have established 
that several antioxidant polyphenolic compounds of 
plant origin such as flavonoids [14] and tannins [15] 
are themselves capable of inducing oxidative damage 
in DNA either alone or in the presence of certain 
transition metal ions especially Cu(II). Further, it 
was also pointed out that several properties of these 
compounds such as binding to DNA and its degrada-
tion are similar to those of known anticancer drugs 
such as bleomycin, adriamycin and 4'-(9-acridinyla-
mino) methanesulphone-m-anisidine (mAMSA) [16-
18]. It has recently been shown that the polyphenolic 
resveratrol is also capable of causing strand breakage 
in DNA in the presence of copper ions [19]. In this 
paper, we have studied some aspects of the mechan-
ism of this reaction and have shown that resveratrol 
forms a complex with Cu(II), leading to its reduction 
to Cu(I) with concomitant formation of reactive 
oxygen species. Furthermore, the reaction presumably 
leads to the formation of 'oxidized product(s)' of 
resveratrol, which also appear to catalyze the reduc-
tion of Cu(II). In addition we have also studied the 
biological activity of the reaction and have shown that 
resveratrol-Cu(II) mediated action causes inactiva-
tion of bacteriophage X. through a mechanism similar 
to DNA breakage. Such studies have implications not 
only for designing novel antitumor agents but may 
also provide an opportunity for more effective 
approaches for prevention and/or control of cancer 
through dietary intervention. 
2. Materials and methods 
2.1. Materials 
Calf thymus DNA (sodium salt; a\ erage molecular 
weight:! X 10*),bathocuproine disulfonic acid, super-
oxide dismutase (SOD) and catalase were purchased 
from Sigma Chemical Company (St. Louis. MO). 
Resveratrol was provided by Pharma Science Inc., 
Canada. Supercoiled plasmid pBR322 DNA was 
prepared according to standard methods [20]. Single 
strand specific nuclease was isolated from pea seeds 
as described previously [21 ]. All other chemicals were 
of analytical grade. Resveratrol was dissolved in cold 
3 niM NaOH before use as a stock solution of 1 mM. 
Upon addition to reaction mixtures, in the presence of 
buffers mentioned in methods (Section 2.2) and at the 
concentrations used, resveratrol remained in solution. 
The volumes of stock solutions added did not lead to 
any appreciable change in the pH of reaction 
mixtures. 
2.2. Methods 
2.2.1. Reaction of resveratrol with calf thymus DNA 
and digestion with single strand specific nuclease 
Reaction mixtures (0.5 ml) contained 10 mM Tris-
HCl (pH 7.5), 500 M-g of DNA, varying amounts of 
resveratrol and cupric chloride. Bathocuproine or 
free radical scavengers were included in some 
experiments. Incubation was performed at 37°C for 
specified time periods. All solutions were sterilized 
before use. Single strand specific nuclease digestion 
was performed as described previously [21]. Acid-
soluble deoxyribonucleotides were determined either 
colorimetrically or by determining the absorbance at 
260 nm. 
2.2.2. Stoichiometry ofCu(l) production 
Varying amounts of resveratrol and cupric chloride 
were added in a total reaction volume of 2 mi 
containing 10 mM Tris-HCl (pH 7.5) and 300 J^LM 
bathocuproine. Bathocuproine-Cu(I) complex was 
determined by measuring the absorbance at 480 nm 
after incubation at room temperature for 10 min. 
2.2.3. Formation of resveratrol-Cu(ll) complex 
Spectrophotometric studies were performed to 
detect the formation of a complex of resveratrol 
with Cu(Il). Reaction mixtures (3 ml) containing 
10 mM Tris-HCl and varying molar ratios of 
Cu(Il)/resveratrol were subjected to spectral analysis. 
2.2.4. Assay of active oxygen species 
Superoxide anion was determined by the reduction 
of nitroblue tetrazolium (NET) to a formazan by the 
method of Nakayama et al. [22]. SOD was included in 
the reaction mixture to confirm the production of 
superoxide anion. Singlet oxygen was measured by 
the method of Kraljic and Mohsni [23] by detecting 
the bleaching of p-nitrosodimethylaniline (pRNO) by 
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resveratrol in the presence of histidine, which serves 
as a selective acceptor of singlet oxygen. Production 
of hydrogen peroxide (H^O;) was assayed by the 
method of Nakayama et al. [22]. Titanium sulfate 
solution was prepared from titanium dioxide [24] 
and diluted so that the final concentration was 1% 
(w/v) Ti(S04) in 1.25 M H^SO*. A 2 ml sample 
containing different amounts of resveratrol was 
mixed with 2 ml of 50 mM sodium phosphate buffer, 
(pH 7.2), and incubated at room temperature for 1 h. 
An aliquot of the mixture was added to 2 ml of a 
titanium sulfate solution. A blank sample was also 
prepared, which did not contain titanium sulfate and 
absorbance was recorded at 410 nm. Catalase 
(100 (jLg/ml) was added in a separate reaction before 
incubation to confirm that the colour change was due 
to the generation of H^Oi. 
2.2.5. Assessment of bacteriophage lambda 
inactivation 
The methods are essentially the same as described 
previously [25]. Bacteriophage lambda was propa-
gated by semiconfluent lysis using indicator Escher-
ichia coli strain AB1157(wild type). The strain of 
phage lambda used was X vir. which contains an abso-
lute defective mutation in the immunity region and, 
therefore, forms clear plaques. 
To assess bacteriophage inactivation, resveratrol 
and a stock of aqueous CuCl; previously sterilized 
by filtration were added to a suspension (0.1 ml.) of 
phage in Tris/Mg-"(0.01 M. (pH 8.0)). CuC^ was 
added 10 min after the addition of resveratrol and the 
reaction mixture was incubated at room temperature 
for specific time periods during which it was vortexed 
at 5 min intervals. In some experiments the quenchers 
of reactive oxygen species and bathocuproine were 
added before the addition of CuCli. For each experi-
ment, parallel control incubations were also 
performed. For experiments in which the indicator 
was pre-treated with UV lighL cells were harvested, 
resuspended and washed 3 times by centrifugation in 
0.15 M NaCl, 0.015 M potassium phosphate buffer 
(pH 7.5) and a final suspension (10* cells/ml.) was 
poured onto a Petri dish to a depth of 3 mm. The 
dish was exposed to an uncalibrated 40 W UV lamp 
from a distance of 20 cm. For experimental assays, the 
viability of the cells used for the assay was determined 
by dilution and plating on nutrient media. 
3. Results 
3.1. Involvement ofCu(I) in resveratrol-Cuill) 
mediated DNA cleavage 
In addition to Cu(II), we have tested several metal 
ions [Co(lI),Fe(Il),Mn(II),Mg(II)andNi(ll)] for their 
ability to complement resveratrol in the DNA clea-
vage reaction. Of the metal ions tested only the 
presence of Cu(II) leads to DNA cleavage in both 
plasmid DNA and calf thymus DNA (results not 
shown). In order to examine the involvement of 
Cu(I) in the reaction we used bathocuproine as an 
agent that sequesters Cu(I) selectively. Resveratrol 
reduces Cu(II) to generate Cu(I) as evidenced by the 
formation of a complex absorbing at 480 nm [15]. The 
reaction possibly leads to the formation of 'oxidized 
species' of resveratrol as in the case of other polyphe-
nolic compounds such as flavonoids [26,27]. Stoichio-
metry of the production of Cu(I) by resveratrol was 
studied (Fig. I) but no clear maximum where absorp-
tion plateaued [15] was obtained, suggesting a possi-
ble recycling of copper ions in the reaction. It would 
thus appear that the 'oxidized species' of resveratrol 
are also able to catalyze the reduction of recycled 
copper ions [Cu(II)]. In order to investigate whether 
sequestration of Cu(I) inhibited DNA breakage, we 
used the single strand specific nuclease assay since 
it is easily quantified. In control experiments, the bath-
1 2 3 4 5 
equivalents of Cu(ll) / resveratrol 
Fig. 1. Detection of stoichiometry of resveratrol and Cu(II) inter-
action. Concentration of bathocuproine used was 300 p.M in all 
cases. Concentrations of resveratrol used were ( • ) 5 \xM and O 
10 nM. The difference in absorbance at 480 nm of samples with and 
without added Cu(II) is plotted vs. equivalents of Cu(Il) per molar 
equivalent of resveratrol. All the points represent triplicate samples 
and mean values have been plotted. 
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ocuproine-Cu(I) complex was shown not to generate 
breaks, confirming the literature data [18]. The 
percentage of inhibition plateaued at a bathocu-
proine/Cu(II) ratio of 2 confirming that Cu(I) is an 
essential intermediate and consistent with a simple 
sequestration mechanism for inhibition as the stoi-
chiometry of the bathocuproine-Cu(I) complex is 
2:1 [15]. 
possibly also capable of reducing recycled Cu(II) to 
Cu(I). In such a case increased copper concentrations 
at a fixed concentration of resveratrol should result in 
increased rate of DNA hydrolysis. As shown in Fig. 3 
this is indeed found to be the case. When calf thymus 
DNA was treated with increasing Cu(II)/resveratrol 
molar ratios a concomitant enhancement in the DNA 
cleaving efficiency was observed. 
3.2. Formation of resyerarrol-Cu(II) complex 
As Cu(n) is reduced to Cu(I) by resveratrol it was 
of interest to determine whether a resveratrol-Cu(II) 
complex is formed. This was carried out by recording 
the absorption spectrum of resveratrol with increasing 
concentrations of CudI). The results given in Fig. 2 
show that the addition of Cu(II) to resveratrol results 
in a shift in the Xnm of resveratrol towards the lower 
wavelength with a peak emerging at 274 nm presum-
ably representing one or more 'oxidized species' of 
resveratrol. The strucmre of these 'oxidized products' 
is not ascertained. As mentioned in the previous 
section the 'oxidized products' of resveratrol are 
290 330 370 
Wov*l«ngth(nm) 
Fig. 2. Formation of resveratrol-Cu(II) complex. The concentration 
of lesveratrol used was 50 iiM. (-). resveratrol alone; ( ), 
resveratrol + 50 jiM Cu(II); ( ). resveratrol + 100 ^MCu(^),• 
(...). resveratrol + 200 jiM Cu(ll). 
3.3. Effect ofresveratrol-Cu(Il) on the viability of 
phage A 
In order to explore the biological consequence of 
the DNA breakage reaction we have tested inactiva-
tion of phage \ by the resveratrol-Cu(II) system. The 
inactivating activity was determined by incubating the 
phage with resveratrol-Cu(II) and then measuring the 
loss of biological activity. Fig. 4 gives the loss of 
survival of phage as a fiinction of the resveratrol 
concentration. Table 1 shows the sensitivity of bacter-
iophage X. to resveratrol-Cu(II) and the effect of UV 
irradiation on the host cells. Control incubations of 
phage with 100 \iM resveratrol alone or 50 p,M 
Cu(II) alone resulted in <5% inactivation. The frac-
tions of surviving phage were 0.22 and 0.42 in the 
case of untreated and UV treated host cells, respec-
tively. It may be noted that at 100 |xM resveratrol 
concentration used in this experiment, the fraction 
of phage survival (0.22) matches the degree of inacti-
vation <0.24) (Fig. 4). One possibility could be that the 
< 
2 
Time( Minutes) 
Fig. 3. Effect of different Cu(Il)/resveratrol molar ratios on calf 
thymus DN.\ degradation. DNA was treated with (O) 0.5:1; ( • ) 1; 1 
and ( • ) 4:1 Cu(IIVresveratrol molar ratios at 37°C for different time 
imenals and subjected to single strand specific nuclease digestion. 
All the points represent triplicate samples and mean values have 
been plonexl. 
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resveratrol cone. (^ lM) 
Rg. 4. Effect of increasing concentrations of resveratrol on the 
viability of phage lambda treated in the presence of Cu(II). The 
concentialioa of Cu(n) was 50 iiM. All the points represent tripli-
cate samples and mean values have been plotted. 
UV inducible pathway is activated on such treatment 
leading to enhanced recovery of the phage. 
3.4. Involvement of oxygen free radicals in the DNA 
breakage and A phage inactivation reactions 
The resveratrol-Cu(n) DNA breakage reaction was 
found to be inhibited by various radical scavengers 
(Table 2, colunui A). Superoxide dismutase (SOD) 
and catalase remove superoxide and HiOi, respec-
tively. Sodium azide is an scavenger of singlet oxygen 
and sodium benzoate and thiourea remove the hydro-
xyl radical. From the data we conclude that H3O2 is an 
essential component in a pathway that leads to reac-
tive oxygen species, of which superoxide anion and 
singlet oxygen are alternate DNA-breakage reagents. 
In column B, the percent inhibition of resveratrol-
Cu(II) mediated X phage inactivation is given. In addi-
tion bathocuproine at a molar ratio of 2 [bathocu-
proine]: 1 [Cu(II)l causes more than 90% inhibition 
of phage inactivation as in the case of DNA breakage 
(Fig. 5). 
5.5. Production of radicals by resveratrol 
Firstly, we determined the production of superoxide 
anion by the method of Nakayama et al. [22], which 
involved reduction of NBT by resveratrol to formazan 
(Table 3). The fact that NBT was genuinely assaying 
superoxide was confirmed by superoxide dismutase 
inhibiting the reaction. Secondly, resveratrol was 
found to generate singlet oxygen in the presence of 
fluorescent light (Fig. 6). This was tested by bleaching 
of pRNO in the presence of histidine, which serves as 
a selective acceptor of singlet oxygen. The bleaching 
of pRNO by resveratrol-Cu(II) system was compared 
with the known producer of singlet oxygen namely, 
riboflavin. That the method assays singlet oxygen was 
confirmed by inhibition of the reaction by sodium 
azide. The hydrogen peroxide production capacity of 
resveratrol was also directly assayed by the method of 
Nakayama et al. [22]. The method involves oxidation 
of titanium to pertitanic acid by hydrogen peroxide. 
The reaction was found to be dose dependent (Fig. 7) 
and was significantly inhibited in the presence of cata-
lase, confirming that the procedure genuinely 
measures hydrogen peroxide. 
4. Discussion 
The major conclusions of the above experiments 
may be stated as follows: (!) resveratrol forms a 
complex with Cu(II) reducing it to Cu(I). In the 
process 'oxidized species' of resveratrol are gener-
ated, which also appear capable of reducing Cu(II); 
(ii) redox cycling of copper leads to generation of 
Table 1 
Scnsitivitv of phage lambda to resveratrol-Cu(II) and the effect of UV-irradiation on the host cells" 
Host strain Host pretreatment Phage pretreatment PFU/ml Survival 
AB1157 
AB1157 
AB1157 
AB1157 
None 
None 
UV 
UV 
Control 
Resveratrol-Cu(II)' 
Control 
Resveralrol-CudD" 
(1.65 ± 0.064) X 10' 
(3.60 ± 0.021) X 10* 
(1.05 ± 0.023) X 10' 
(4.40 ± 0.056) X 10* 
1 
0.22 
1 
0.42 
* Incubation was done for I h at 37°C followed by dilution and plating. All values are expressed as mean ± SE for three different experiments. 
' The value of survival was calculated by dividing values in the presence of resveratrol-Cu(Il) by control values. 
' Concentrations of resveratrol and Cufll) used v.ere 100 and 50 jxM, respectively. 
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Table! 
Percent inhibition of single strand specific nuclease hydrolysis of DNA and \ inactivation after treatment with resveratrol (100 piM) and CudI) 
(50 fiM) in the presence of scavengers' 
Conditions Inhibition (%) 9f- Inhibition of X. inactivation 
CataIase(IOO|ig/mI) 
Boiled catalase (100 |ig/ml) 
Sodium azide (SO mM) 
Sodium benzoate (SO mM) 
Thiourea (SO mM) 
SOD''(I00KLg/nU) 
Bathocuproine (2(X) |iM) 
87.97 ± 2.05 
26.04 ± 0.78 
66.01 ± 2.96 
32.02 ± 0.65 
0 
36.03 ± 2.69 
94.02 ± 2.43 
78.57 ± 3.08 
50.89 ± 1.33 
26.79 ± 0.96 
4.89 ±0.15 
37.5 ± 0.70 
93.75 ± 1.37 
* All values are expressed as mean ± SE for three diffetent experiments. 
*" SOD, superoxide dismutase. 
various reactive oxygen species, which serve as 
proximal DNA cleaving and bacteriophage inacti-
vating agents. These results place resveratrol in a 
class of plant derived polyphenolic antioxidants 
such as flavonoids [14] and tannins [15], which 
also exhibit prooxidant DNA damaging properties. 
The generation of oxygen radicals in the proximity 
of DNA is well established as a cause of strand 
scission [14,15,28]. It is generally recognized that 
such reactions with DNA are preceded by the asso-
ciation of the ligand with DNA, followed by the 
production of oxygen radicals at that site [29]. 
Degradation by 4-(9-acridinylamino)methanesul-
phone-m-anisidine [18], bleomycin [16], adriamycin 
[17] as well as flavonoids [14,28] is dependent upon 
metal ions by mechanisms involving oxygen derived 
c 
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Bathocuproine cone. (^M) 
Fig. 5. Effect of increasing concentrations of bathocuproine on the 
viability of resveratrol-Cu(II) treated phage lambda. The concen-
trations of resveratrol and Cu(II) were 100 and 50 (iM, respectively. 
All the points represent triplicate samples and mean values have 
been plotted. 
radicals. In these studies, it was shown that a ternary 
complex of the drug, DNA and Cu(II) is formed, 
which generates oxygen radicals in situ via Cu(I). 
Our results show that resveratrol binds to Cu(ll). 
Fukuhara and Miyata [19] have demonstrated that 
resveratrol is capable of binding to DNA and. 
thus, it would be reasonable to assume that a similar 
mechanism operates in the case of resveratrol-
Cu(n) mediated DNA cleavage. Further, the results 
with oxygen radical scavengers (Table 2) indicate 
that quenchers of hydroxyl radical particularly 
thiourea are not very effective in inhibiting both 
the DNA cleavage as well as phage inactivation, 
whereas catalase is the most effective quencher in 
both cases. This observation is in support of the 
findings of Fukuhara and Miyata who have proposed 
that Cu(II) dependent DNA damage by resveratrol 
is caused predominantly by a copper-peroxide 
comple.\ rather than by a freely diffusable oxygen 
species. These authors have further suggested that 
the reaction occurs without oxygenated transforma-
tion of benzene nuclei. However, our results indicate 
(Fig. 2) that 'transformed species' of resveratrol. 
possible oxidized forms, are produced in the 
presence of Cu(Il). It is possible that more than 
one mechanism of DNA cleavage is involved. This 
is further suggested by the effect of hydroxyl radical 
and singlet oxygen quenchers (such as sodium 
benzoate and sodium azide), which cause partial 
inhibition of both DNA cleavage as well as phage 
inactivation. 
In addition to chemoprevention of cancer, resvera-
trol has also been shown to possess apoptotic activity 
in human tumor cells [12,13]. Resveratrol can be 
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Table 3 
Rate of production of superoxide anion from the solution of resver-
atrol as assayed by reduction of nitroblue tetrazolium to formazan 
Resveratrol concentration {^lM) 
5 
10 
15 
20 
40 
60 
80 
100 
100[+SOD(100jig/ml)] 
Formazan produced ()jiM) 
0.133 
0.400 
0.866 
1.133 
2.466 
3.666 
5.330 
7.260 
2.800 
absorbed from dietary material as shown by its 
presence in plasma, heart, liver and kidney upon 
ingestion of red wine in rats [SOJ. Also, it is known 
that red wine is a good source of c(q>per [31,32]. 
Copper is an essential constituent of many enzymes 
such as tyrosinase and superoxide dismutase. Normal 
serum contains up to 8 (iM loosely bound copper and 
other biological fluids may also contain comparable 
amounts [33]. Lxrasely bound copper has been defined 
by Gutteridge [33] as that copper, which is available 
Time ( Minutes ) 
Fig. 6. Singlet o.xygen production by resveratrol under fluorescent 
light. Generation of singlet oxygen was measured by recording 
decrease in the absorption of p-nitrosodimethylaniline (pRNO) 
solution (30 (JLM in 10 m-M potassium-phosphate buffer, (pH 8.0)) 
containing 10 mM histidine as a selective acceptor of singlet 
oxygen. Concentration of resveratrol was 100 (iM. (D), pRNO 
alone; (O). pRNO + resveratrol - CuCOi (100 (iM) + sodium 
azide (50 mM): (•) , pRNO + resveratrol + Cu(n) (100 (iM); 
(•) , pRNO + riboflavin (1.5 ng/ml). All the points represent tripli-
cate samples and mean values have been plotted. 
for binding to the chelating agent 1,10-phenanthro-
line. It is possible that such loosely bound copper 
can also be mobilized by resveratrol. Copper has 
also been reported to be a normal component of chro-
matin and such endogenous copper can be mobilized 
by chemical agents such as 1,10-phenanthroline to 
cause intemucleosomal DNA fragmentation [34]. 
Since resveratrol has been detected in tissues such 
as kidney and liver it is reasonable to assume that it 
is transported across cell membranes because of its 
lipophilic nature. It may be mentioned that it has 
been shown to bind to lipoproteins in plasma [35]. 
Further, resveratrol would be rendered more lipophi-
lic as a complex with copper. It may be further 
mentioned that the apoptotic activity of the antioxi-
dant gallic acid is abolished on modification of pheno-
lic hydroxyl groups (required for copper chelation) 
[36]. This result correlates with our previous observa-
tion where we have shown that such a modification of 
gallic acid resulting in the formation of syringic acid 
also considerably reduces the DNA cleavage effi-
ciency in the presence of Cu(II) [37]. It has recently 
been reported that another polyphenolic antioxidant 
curcumin also induces apoptosis in human leukemia 
cells and that such apoptosis is prevented by super-
oxide dismutase or catalase [38]. It would thus appear 
that prooxidant action of polyphenolics rather than the 
antioxidant activity is responsible for the induction of 
apoptosis in these studies. Thus, one of the mechan-
isms could be that in tumour cells endogenous copper 
Resveratrol ( \x moles ) 
Fig. 7. Generation of hydrogen peroxide by increasing concentra-
tions of resveratrol. ( • ) , resveratrol alone; (O), resveratrol -(- cata-
lase (1(X) (ig/ml). All the points represent triplicate samples and 
mean values have been plotted. 
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in serum or chromatin is relatively easily mobilized 
by polyphenolic compounds and similar apoptosis 
inducing agents. Irrespective of the physiological 
significance of our results it is clear that resveratrol 
as a lead compound has implications for the develop-
ment of novel antitumor and cancer chemopreventive 
agents. 
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